{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task-related articles and sentences retrieval based on two-level of tf-idf with result summary for each task.\n",
    "#### Goal\n",
    "Given a large number of literature and queries of interest, retrieve the most relevant information to the queries from the literature. \n",
    "#### Approach\n",
    "Since there is no ground-truth answer to each task, we model each task as an information retrieval problem and adopt the tf-idf features to quantize the similarity between queries of each task and articles. Specifically, we implement a two-level tf-idf information retrieval system. On the first level, the most relevant articles are retrieved for each task. On the second level, the most relevant sentences are retrieved from the articles retrieved on the first level. The articles/sentences are ranked based on cosine similarity between tf-idf feature vectors of articles/sentences and the target query. The same approach is applicable to all 10 tasks in this challenge. Once all the articles are vectorized and indexed, they can be reloaded to quickly respond to different queries of different tasks without re-training.\n",
    "#### Afterwards analyses\n",
    "At the end of this notebook, we also provide a mixed short-cut for the articles and sentences we retrieved for each of the 10 tasks. This summary of results may not represent a professional or comprehensive analysis of all available COVID-19 studies so far, but may still serve as a reference that we hope may help inspire further examinations. We are submitting the same notebook to all tasks in case the reviewers of one task may also be interested to see the results for other tasks."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import os\n",
    "from os import listdir\n",
    "from os.path import isfile, join\n",
    "import collections\n",
    "import re\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from nltk.tokenize import word_tokenize, sent_tokenize\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import LancasterStemmer, PorterStemmer, SnowballStemmer, WordNetLemmatizer\n",
    "import time\n",
    "import string\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from scipy.spatial.distance import cdist\n",
    "import pickle\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# I. Metadata basic statistics\n",
    "We first examine the metadata to gain a deeper understanding of the dataset. We pay more attention to the abstracts as an abstract is usually a high-level summary of the discovery of a study, thus it is information-enriched. In addition, while less than half of the articles have a full-text available, most articles have an abstract provided."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Read-in metadata"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of articles: 29500\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>c630ebcdf30652f0422c3ec12a00b50241dc9bd9</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Angiotensin-converting enzyme 2 (ACE2) as a SA...</td>\n",
       "      <td>10.1007/s00134-020-05985-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125455.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>2.002765e+09</td>\n",
       "      <td>#3252</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>53eccda7977a31e3d0f565c884da036b1e85438e</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Comparative genetic analysis of the novel coro...</td>\n",
       "      <td>10.1038/s41421-020-0147-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...</td>\n",
       "      <td>Cell Discovery</td>\n",
       "      <td>3.003431e+09</td>\n",
       "      <td>#1861</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>210a892deb1c61577f6fba58505fd65356ce6636</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Incubation Period and Other Epidemiological Ch...</td>\n",
       "      <td>10.3390/jcm9020538</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>The geographic spread of 2019 novel coronaviru...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...</td>\n",
       "      <td>Journal of Clinical Medicine</td>\n",
       "      <td>3.006065e+09</td>\n",
       "      <td>#1043</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>e3b40cc8e0e137c416b4a2273a4dca94ae8178cc</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Characteristics of and Public Health Responses...</td>\n",
       "      <td>10.3390/jcm9020575</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32093211.0</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>In December 2019, cases of unidentified pneumo...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Deng, Sheng-Qun; Peng, Hong-Juan</td>\n",
       "      <td>J Clin Med</td>\n",
       "      <td>1.776631e+08</td>\n",
       "      <td>#1999</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>92c2c9839304b4f2bc1276d41b1aa885d8b364fd</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Imaging changes in severe COVID-19 pneumonia</td>\n",
       "      <td>10.1007/s00134-020-05976-w</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125453.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Wei</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>3.006643e+09</td>\n",
       "      <td>#3242</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha source_x  \\\n",
       "0  c630ebcdf30652f0422c3ec12a00b50241dc9bd9      CZI   \n",
       "1  53eccda7977a31e3d0f565c884da036b1e85438e      CZI   \n",
       "2  210a892deb1c61577f6fba58505fd65356ce6636      CZI   \n",
       "3  e3b40cc8e0e137c416b4a2273a4dca94ae8178cc      CZI   \n",
       "4  92c2c9839304b4f2bc1276d41b1aa885d8b364fd      CZI   \n",
       "\n",
       "                                               title  \\\n",
       "0  Angiotensin-converting enzyme 2 (ACE2) as a SA...   \n",
       "1  Comparative genetic analysis of the novel coro...   \n",
       "2  Incubation Period and Other Epidemiological Ch...   \n",
       "3  Characteristics of and Public Health Responses...   \n",
       "4       Imaging changes in severe COVID-19 pneumonia   \n",
       "\n",
       "                          doi pmcid   pubmed_id   license  \\\n",
       "0  10.1007/s00134-020-05985-9   NaN  32125455.0  cc-by-nc   \n",
       "1   10.1038/s41421-020-0147-1   NaN         NaN     cc-by   \n",
       "2          10.3390/jcm9020538   NaN         NaN     cc-by   \n",
       "3          10.3390/jcm9020575   NaN  32093211.0     cc-by   \n",
       "4  10.1007/s00134-020-05976-w   NaN  32125453.0  cc-by-nc   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0                                                NaN         2020   \n",
       "1                                                NaN         2020   \n",
       "2  The geographic spread of 2019 novel coronaviru...         2020   \n",
       "3  In December 2019, cases of unidentified pneumo...         2020   \n",
       "4                                                NaN         2020   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...   \n",
       "1  Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...   \n",
       "2  Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...   \n",
       "3                   Deng, Sheng-Qun; Peng, Hong-Juan   \n",
       "4                                         Zhang, Wei   \n",
       "\n",
       "                        journal  Microsoft Academic Paper ID WHO #Covidence  \\\n",
       "0            Intensive Care Med                 2.002765e+09          #3252   \n",
       "1                Cell Discovery                 3.003431e+09          #1861   \n",
       "2  Journal of Clinical Medicine                 3.006065e+09          #1043   \n",
       "3                    J Clin Med                 1.776631e+08          #1999   \n",
       "4            Intensive Care Med                 3.006643e+09          #3242   \n",
       "\n",
       "  has_full_text  \n",
       "0          True  \n",
       "1          True  \n",
       "2          True  \n",
       "3          True  \n",
       "4         False  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#metaDataPath = \"/kaggle/input/CORD-19-research-challenge/2020-03-13/all_sources_metadata_2020-03-13.csv\"\n",
    "metaDataPath = \"~/Downloads/2020-03-13/all_sources_metadata_2020-03-13.csv\"\n",
    "metaData = pd.read_csv(metaDataPath, header = 0)\n",
    "print(\"The number of articles: \" + str(metaData.shape[0]))\n",
    "metaData.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Nan elements counts in all columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "sha                            12080\n",
       "source_x                           0\n",
       "title                            370\n",
       "doi                             3143\n",
       "pmcid                           2163\n",
       "pubmed_id                      12770\n",
       "license                        11808\n",
       "abstract                        2947\n",
       "publish_time                   11252\n",
       "authors                          946\n",
       "journal                        11709\n",
       "Microsoft Academic Paper ID    28366\n",
       "WHO #Covidence                 28264\n",
       "has_full_text                  12080\n",
       "dtype: int64"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metaData.isnull().sum()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Literature source distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "sourceDic = collections.defaultdict(int)\n",
    "for s in metaData[\"source_x\"][metaData[\"source_x\"].notnull()]:\n",
    "    sourceDic[s] += 1\n",
    "sizes = []\n",
    "explode = []\n",
    "labels = []\n",
    "for s in sourceDic:\n",
    "    sizes.append(sourceDic[s])\n",
    "    explode.append(0)\n",
    "    labels.append(s)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "colors = ['gold', 'lightskyblue', 'yellowgreen', 'lightcoral']\n",
    "plt.pie(sizes, explode=explode, labels=labels, colors = colors, autopct='%1.1f%%', shadow=True, startangle=140)\n",
    "plt.axis('equal')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 4. Publish year distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "yearList = []\n",
    "for y in metaData[\"publish_time\"][metaData[\"publish_time\"].notnull()]:\n",
    "    yearList.append(int(re.split(' |-', y)[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0, 0.5, 'Frequency')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.distplot(yearList, bins = 50)\n",
    "plt.xlabel(\"Year\")\n",
    "plt.ylabel(\"Frequency\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "A lot more coronaviruses related articles published in the past 10 years."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. Has full text distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of articles with full text: 13219\n",
      "The number of articles without full text: 16281\n"
     ]
    }
   ],
   "source": [
    "hasFullText = metaData[\"has_full_text\"][metaData[\"has_full_text\"].notnull()]\n",
    "nanCount = metaData.shape[0] - hasFullText.shape[0]\n",
    "trueCount = sum(hasFullText)\n",
    "falseCount = hasFullText.shape[0] - trueCount\n",
    "print(\"The number of articles with full text: \" + str(trueCount))\n",
    "print(\"The number of articles without full text: \" + str(falseCount + nanCount))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 6. Abstract distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of articles with abstract: 26553\n"
     ]
    }
   ],
   "source": [
    "print(\"The number of articles with abstract: \" + str(sum(metaData[\"abstract\"].notnull())))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we try to normalize the abstracts to learn the distribution of abstract length and tokens. The following steps will also be the steps to preprocess the abstracts for extracting tf-idf features."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time spent: 2.217min.\n",
      "The number of tokens: 50493\n"
     ]
    }
   ],
   "source": [
    "startTime = time.time()\n",
    "absLength = []\n",
    "word2count = {}\n",
    "for abstract in metaData[\"abstract\"][metaData[\"abstract\"].notnull()]:\n",
    "    ## Remove web links\n",
    "    abstract = re.sub('https?://\\S+|www\\.\\S+', '', abstract) \n",
    "\n",
    "    ## Lowercase\n",
    "    abstract = abstract.lower()\n",
    "    \n",
    "    ## Remove punctuation\n",
    "    abstract = re.sub('<.*?>+', ' ', abstract)\n",
    "    abstract = re.sub('[%s]' % re.escape(string.punctuation), ' ', abstract)\n",
    "    \n",
    "    ## Remove number\n",
    "    abstract = re.sub(r'\\d+', '', abstract)\n",
    "    \n",
    "    ## Tokenize\n",
    "    words = word_tokenize(abstract)\n",
    "    \n",
    "    ## Remove stop words\n",
    "    nltk_stop_words = stopwords.words('english')\n",
    "    words = [word for word in words if word not in nltk_stop_words]\n",
    "    \n",
    "    ## Stem\n",
    "    stemmer = SnowballStemmer('english')\n",
    "    words = [stemmer.stem(word) for word in words]\n",
    "    \n",
    "    ## Lematize verbs\n",
    "    lemmatizer = WordNetLemmatizer()\n",
    "    words = [lemmatizer.lemmatize(word, pos='v') for word in words]\n",
    "    \n",
    "    ## Record length\n",
    "    absLength.append(len(words))\n",
    "    \n",
    "    ## Get word count\n",
    "    for word in words:\n",
    "        count = word2count.get(word, 0)\n",
    "        word2count[word] = count + 1\n",
    "print(\"Time spent: \" + str(round((time.time() - startTime) / 60, 3)) + \"min.\")\n",
    "print(\"The number of tokens: \" + str(len(word2count)))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Distribution of abstract length\n",
    "There are 20 extremely long abstracts. We excluded them from the histogram."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.distplot(sorted(absLength)[:-20], bins = 50) # There are 20 extremely long abstracts\n",
    "plt.xlabel(\"Abstract token count\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Top 50 mostly frequent tokens"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x140b7ce10>"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_word_count = pd.DataFrame(sorted(word2count.items(), key=lambda x: x[1])[::-1])\n",
    "sns.set(rc={'figure.figsize':(12,10)})\n",
    "sns.barplot(y = df_word_count[0].values[:50], x = df_word_count[1].values[:50], color='red')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# II. Article and sentence retrieval\n",
    "Now let's start building the system for article and sentence retrieval. For the first level of retrieving articles, we build a tf-idf vectorizer for all articles based on their abstracts. Therefore, whether an article is considered related to a query is only based on the content in its abstract. The reasons we didn't include all text from the article is that 1. most articles don't have a full-text available; 2. abstract as a high-level summary of the discovery of the article is more information-enriched compared to the full-text; 3. only including the abstract will largely reduce the vectorizer learning time. For the second level of retrieving sentences, we first retrieving relevant articles. Then from the abstracts and paragraphs in discussion and/or conclusion sections (if exist) of the articles build a second vectorizer and retrieve the most relevant sentences. The reason we only take abstract, discussion and conclusion into consideration is that for most tasks in this challenge, the questions of interest are mostly high-level questions, to which the related information is more likely to be in summary sections rather than experiments or results sections. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Preprocess metadata\n",
    "This section only needs to be run once. The new metadata table with the normalized abstracts in the column \"clean_abstract\" will be saved to all_sources_metadata_2020-03-13_clean.csv in the output folder."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "def textNormalize(rawString):\n",
    "    \"\"\"\n",
    "    Function for text normalization.\n",
    "    Text normalization includes:\n",
    "    1. removing web links\n",
    "    2. converting all letters to lower or upper case\n",
    "    3. removing punctuations\n",
    "    4. removing numbers\n",
    "    5. tokenization\n",
    "    6. removing stopwords\n",
    "    7. stemming\n",
    "    8. lemmatization\n",
    "    Input:\n",
    "        rawString: a string contains the text to be normaized. \n",
    "    Output:\n",
    "        normText: a string contains the normalized text where the tokens extracted from rawString are joined by space.\n",
    "    \"\"\"\n",
    "    if rawString == np.nan:\n",
    "        return rawString\n",
    "    ## Remove web links\n",
    "    rawString = re.sub('https?://\\S+|www\\.\\S+', '', rawString) \n",
    "\n",
    "    ## Lowercase\n",
    "    rawString = rawString.lower()\n",
    "    \n",
    "    ## Remove punctuation\n",
    "    rawString = re.sub('<.*?>+', ' ', rawString)\n",
    "    rawString = re.sub('[%s]' % re.escape(string.punctuation), ' ', rawString)\n",
    "    \n",
    "    ## Remove number\n",
    "    rawString = re.sub(r'\\d+', '', rawString)\n",
    "    \n",
    "    ## Tokenize\n",
    "    words = word_tokenize(rawString)\n",
    "    \n",
    "    ## Remove stop words\n",
    "    nltk_stop_words = stopwords.words('english')\n",
    "    words = [word for word in words if word not in nltk_stop_words]\n",
    "    \n",
    "    ## Stem\n",
    "    stemmer = SnowballStemmer('english')\n",
    "    words = [stemmer.stem(word) for word in words]\n",
    "    \n",
    "    ## Lematize verbs\n",
    "    lemmatizer = WordNetLemmatizer()\n",
    "    words = [lemmatizer.lemmatize(word, pos='v') for word in words]\n",
    "    \n",
    "    normText = \" \".join(words)\n",
    "    \n",
    "    return normText"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Read-in metadata"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of articles: 29500\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>c630ebcdf30652f0422c3ec12a00b50241dc9bd9</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Angiotensin-converting enzyme 2 (ACE2) as a SA...</td>\n",
       "      <td>10.1007/s00134-020-05985-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125455.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>2.002765e+09</td>\n",
       "      <td>#3252</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>53eccda7977a31e3d0f565c884da036b1e85438e</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Comparative genetic analysis of the novel coro...</td>\n",
       "      <td>10.1038/s41421-020-0147-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...</td>\n",
       "      <td>Cell Discovery</td>\n",
       "      <td>3.003431e+09</td>\n",
       "      <td>#1861</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>210a892deb1c61577f6fba58505fd65356ce6636</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Incubation Period and Other Epidemiological Ch...</td>\n",
       "      <td>10.3390/jcm9020538</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>The geographic spread of 2019 novel coronaviru...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...</td>\n",
       "      <td>Journal of Clinical Medicine</td>\n",
       "      <td>3.006065e+09</td>\n",
       "      <td>#1043</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>e3b40cc8e0e137c416b4a2273a4dca94ae8178cc</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Characteristics of and Public Health Responses...</td>\n",
       "      <td>10.3390/jcm9020575</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32093211.0</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>In December 2019, cases of unidentified pneumo...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Deng, Sheng-Qun; Peng, Hong-Juan</td>\n",
       "      <td>J Clin Med</td>\n",
       "      <td>1.776631e+08</td>\n",
       "      <td>#1999</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>92c2c9839304b4f2bc1276d41b1aa885d8b364fd</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Imaging changes in severe COVID-19 pneumonia</td>\n",
       "      <td>10.1007/s00134-020-05976-w</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125453.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Wei</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>3.006643e+09</td>\n",
       "      <td>#3242</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha source_x  \\\n",
       "0  c630ebcdf30652f0422c3ec12a00b50241dc9bd9      CZI   \n",
       "1  53eccda7977a31e3d0f565c884da036b1e85438e      CZI   \n",
       "2  210a892deb1c61577f6fba58505fd65356ce6636      CZI   \n",
       "3  e3b40cc8e0e137c416b4a2273a4dca94ae8178cc      CZI   \n",
       "4  92c2c9839304b4f2bc1276d41b1aa885d8b364fd      CZI   \n",
       "\n",
       "                                               title  \\\n",
       "0  Angiotensin-converting enzyme 2 (ACE2) as a SA...   \n",
       "1  Comparative genetic analysis of the novel coro...   \n",
       "2  Incubation Period and Other Epidemiological Ch...   \n",
       "3  Characteristics of and Public Health Responses...   \n",
       "4       Imaging changes in severe COVID-19 pneumonia   \n",
       "\n",
       "                          doi pmcid   pubmed_id   license  \\\n",
       "0  10.1007/s00134-020-05985-9   NaN  32125455.0  cc-by-nc   \n",
       "1   10.1038/s41421-020-0147-1   NaN         NaN     cc-by   \n",
       "2          10.3390/jcm9020538   NaN         NaN     cc-by   \n",
       "3          10.3390/jcm9020575   NaN  32093211.0     cc-by   \n",
       "4  10.1007/s00134-020-05976-w   NaN  32125453.0  cc-by-nc   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0                                                NaN         2020   \n",
       "1                                                NaN         2020   \n",
       "2  The geographic spread of 2019 novel coronaviru...         2020   \n",
       "3  In December 2019, cases of unidentified pneumo...         2020   \n",
       "4                                                NaN         2020   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...   \n",
       "1  Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...   \n",
       "2  Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...   \n",
       "3                   Deng, Sheng-Qun; Peng, Hong-Juan   \n",
       "4                                         Zhang, Wei   \n",
       "\n",
       "                        journal  Microsoft Academic Paper ID WHO #Covidence  \\\n",
       "0            Intensive Care Med                 2.002765e+09          #3252   \n",
       "1                Cell Discovery                 3.003431e+09          #1861   \n",
       "2  Journal of Clinical Medicine                 3.006065e+09          #1043   \n",
       "3                    J Clin Med                 1.776631e+08          #1999   \n",
       "4            Intensive Care Med                 3.006643e+09          #3242   \n",
       "\n",
       "  has_full_text  \n",
       "0          True  \n",
       "1          True  \n",
       "2          True  \n",
       "3          True  \n",
       "4         False  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#metaDataPath = \"/kaggle/input/CORD-19-research-challenge/2020-03-13/all_sources_metadata_2020-03-13.csv\"\n",
    "metaDataPath = \"~/Downloads/2020-03-13/all_sources_metadata_2020-03-13.csv\"\n",
    "metaData = pd.read_csv(metaDataPath, header = 0)\n",
    "print(\"The number of articles: \" + str(metaData.shape[0]))\n",
    "metaData.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Normalize abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time spent: 2.068min.\n"
     ]
    }
   ],
   "source": [
    "startTime = time.time()\n",
    "metaData[\"clean_abstract\"] = float(\"NaN\")\n",
    "metaData.loc[metaData[\"abstract\"].notnull(), \"clean_abstract\"] = \\\n",
    "metaData[\"abstract\"][metaData[\"abstract\"].notnull()].apply(lambda x: textNormalize(x))\n",
    "print(\"Time spent: \" + str(round((time.time() - startTime) / 60, 3)) + \"min.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Output the new metadata table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "metaData.to_csv(\"~/Downloads/2020-03-13/all_sources_metadata_2020-03-13_clean.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Learn tf-idf vectorizer"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This section only needs to be run once. A tf-idf vectorizer will be learned from the normalized abstracts and saved to tf-idf_vectorizer.pkl in the output folder."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Read-in metadata with normalized abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "      <th>clean_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>c630ebcdf30652f0422c3ec12a00b50241dc9bd9</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Angiotensin-converting enzyme 2 (ACE2) as a SA...</td>\n",
       "      <td>10.1007/s00134-020-05985-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125455.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>2.002765e+09</td>\n",
       "      <td>#3252</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>53eccda7977a31e3d0f565c884da036b1e85438e</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Comparative genetic analysis of the novel coro...</td>\n",
       "      <td>10.1038/s41421-020-0147-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...</td>\n",
       "      <td>Cell Discovery</td>\n",
       "      <td>3.003431e+09</td>\n",
       "      <td>#1861</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>210a892deb1c61577f6fba58505fd65356ce6636</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Incubation Period and Other Epidemiological Ch...</td>\n",
       "      <td>10.3390/jcm9020538</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>The geographic spread of 2019 novel coronaviru...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...</td>\n",
       "      <td>Journal of Clinical Medicine</td>\n",
       "      <td>3.006065e+09</td>\n",
       "      <td>#1043</td>\n",
       "      <td>True</td>\n",
       "      <td>geograph spread novel coronavirus covid infect...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>e3b40cc8e0e137c416b4a2273a4dca94ae8178cc</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Characteristics of and Public Health Responses...</td>\n",
       "      <td>10.3390/jcm9020575</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32093211.0</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>In December 2019, cases of unidentified pneumo...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Deng, Sheng-Qun; Peng, Hong-Juan</td>\n",
       "      <td>J Clin Med</td>\n",
       "      <td>1.776631e+08</td>\n",
       "      <td>#1999</td>\n",
       "      <td>True</td>\n",
       "      <td>decemb case unidentifi pneumonia histori expos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>92c2c9839304b4f2bc1276d41b1aa885d8b364fd</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Imaging changes in severe COVID-19 pneumonia</td>\n",
       "      <td>10.1007/s00134-020-05976-w</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125453.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Wei</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>3.006643e+09</td>\n",
       "      <td>#3242</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                       sha source_x  \\\n",
       "0           0  c630ebcdf30652f0422c3ec12a00b50241dc9bd9      CZI   \n",
       "1           1  53eccda7977a31e3d0f565c884da036b1e85438e      CZI   \n",
       "2           2  210a892deb1c61577f6fba58505fd65356ce6636      CZI   \n",
       "3           3  e3b40cc8e0e137c416b4a2273a4dca94ae8178cc      CZI   \n",
       "4           4  92c2c9839304b4f2bc1276d41b1aa885d8b364fd      CZI   \n",
       "\n",
       "                                               title  \\\n",
       "0  Angiotensin-converting enzyme 2 (ACE2) as a SA...   \n",
       "1  Comparative genetic analysis of the novel coro...   \n",
       "2  Incubation Period and Other Epidemiological Ch...   \n",
       "3  Characteristics of and Public Health Responses...   \n",
       "4       Imaging changes in severe COVID-19 pneumonia   \n",
       "\n",
       "                          doi pmcid   pubmed_id   license  \\\n",
       "0  10.1007/s00134-020-05985-9   NaN  32125455.0  cc-by-nc   \n",
       "1   10.1038/s41421-020-0147-1   NaN         NaN     cc-by   \n",
       "2          10.3390/jcm9020538   NaN         NaN     cc-by   \n",
       "3          10.3390/jcm9020575   NaN  32093211.0     cc-by   \n",
       "4  10.1007/s00134-020-05976-w   NaN  32125453.0  cc-by-nc   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0                                                NaN         2020   \n",
       "1                                                NaN         2020   \n",
       "2  The geographic spread of 2019 novel coronaviru...         2020   \n",
       "3  In December 2019, cases of unidentified pneumo...         2020   \n",
       "4                                                NaN         2020   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...   \n",
       "1  Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...   \n",
       "2  Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...   \n",
       "3                   Deng, Sheng-Qun; Peng, Hong-Juan   \n",
       "4                                         Zhang, Wei   \n",
       "\n",
       "                        journal  Microsoft Academic Paper ID WHO #Covidence  \\\n",
       "0            Intensive Care Med                 2.002765e+09          #3252   \n",
       "1                Cell Discovery                 3.003431e+09          #1861   \n",
       "2  Journal of Clinical Medicine                 3.006065e+09          #1043   \n",
       "3                    J Clin Med                 1.776631e+08          #1999   \n",
       "4            Intensive Care Med                 3.006643e+09          #3242   \n",
       "\n",
       "  has_full_text                                     clean_abstract  \n",
       "0          True                                                NaN  \n",
       "1          True                                                NaN  \n",
       "2          True  geograph spread novel coronavirus covid infect...  \n",
       "3          True  decemb case unidentifi pneumonia histori expos...  \n",
       "4         False                                                NaN  "
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metaDataPath = \"~/Downloads/2020-03-13/all_sources_metadata_2020-03-13_clean.csv\"\n",
    "metaData = pd.read_csv(metaDataPath, header = 0)\n",
    "metaData.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Learn vocabulary and idf from the normalized abstracts\n",
    "To further constrain the searching space to focus more on coronavirus knowledge, we only include an article if either \"coron\" (for coronavirus) or \"covid\" are mentioned in its abstract. In this way, other articles that are more generally related to epidemic or other respiration diseases will be excluded. This filtering step also largely boosts learning and retrieval time. More strict rules can also be used to only include articles that are specifically related to COVID-19."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of remaining articles:  5246\n"
     ]
    }
   ],
   "source": [
    "metaData = metaData[metaData[\"clean_abstract\"].notnull()]\n",
    "metaData = metaData[metaData[\"clean_abstract\"].str.contains(\"|\".join([\"coron\", \"covid\"]))]\n",
    "print(\"The number of remaining articles: \", metaData.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time spent: 3.8996529579162598s.\n"
     ]
    }
   ],
   "source": [
    "startTime = time.time()\n",
    "vectorizer = TfidfVectorizer(tokenizer = word_tokenize)\n",
    "vectorizer.fit(metaData[\"clean_abstract\"][metaData[\"clean_abstract\"].notnull()])\n",
    "print('Time spent: ' + str(time.time() - startTime) + 's.')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Save the learned vectorizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "vectPath = \"../../../Downloads/2020-03-13/tf-idf_vectorizer.pkl\"\n",
    "with open(vectPath, \"wb\") as vectFile:\n",
    "    pickle.dump(vectorizer, vectFile)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Retrieve relevant articles and sentences for each task"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Read-in metadata with normalized abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "      <th>clean_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>c630ebcdf30652f0422c3ec12a00b50241dc9bd9</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Angiotensin-converting enzyme 2 (ACE2) as a SA...</td>\n",
       "      <td>10.1007/s00134-020-05985-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125455.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>2.002765e+09</td>\n",
       "      <td>#3252</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>53eccda7977a31e3d0f565c884da036b1e85438e</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Comparative genetic analysis of the novel coro...</td>\n",
       "      <td>10.1038/s41421-020-0147-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...</td>\n",
       "      <td>Cell Discovery</td>\n",
       "      <td>3.003431e+09</td>\n",
       "      <td>#1861</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>210a892deb1c61577f6fba58505fd65356ce6636</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Incubation Period and Other Epidemiological Ch...</td>\n",
       "      <td>10.3390/jcm9020538</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>The geographic spread of 2019 novel coronaviru...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...</td>\n",
       "      <td>Journal of Clinical Medicine</td>\n",
       "      <td>3.006065e+09</td>\n",
       "      <td>#1043</td>\n",
       "      <td>True</td>\n",
       "      <td>geograph spread novel coronavirus covid infect...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>e3b40cc8e0e137c416b4a2273a4dca94ae8178cc</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Characteristics of and Public Health Responses...</td>\n",
       "      <td>10.3390/jcm9020575</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32093211.0</td>\n",
       "      <td>cc-by</td>\n",
       "      <td>In December 2019, cases of unidentified pneumo...</td>\n",
       "      <td>2020</td>\n",
       "      <td>Deng, Sheng-Qun; Peng, Hong-Juan</td>\n",
       "      <td>J Clin Med</td>\n",
       "      <td>1.776631e+08</td>\n",
       "      <td>#1999</td>\n",
       "      <td>True</td>\n",
       "      <td>decemb case unidentifi pneumonia histori expos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>92c2c9839304b4f2bc1276d41b1aa885d8b364fd</td>\n",
       "      <td>CZI</td>\n",
       "      <td>Imaging changes in severe COVID-19 pneumonia</td>\n",
       "      <td>10.1007/s00134-020-05976-w</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32125453.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Zhang, Wei</td>\n",
       "      <td>Intensive Care Med</td>\n",
       "      <td>3.006643e+09</td>\n",
       "      <td>#3242</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                       sha source_x  \\\n",
       "0           0  c630ebcdf30652f0422c3ec12a00b50241dc9bd9      CZI   \n",
       "1           1  53eccda7977a31e3d0f565c884da036b1e85438e      CZI   \n",
       "2           2  210a892deb1c61577f6fba58505fd65356ce6636      CZI   \n",
       "3           3  e3b40cc8e0e137c416b4a2273a4dca94ae8178cc      CZI   \n",
       "4           4  92c2c9839304b4f2bc1276d41b1aa885d8b364fd      CZI   \n",
       "\n",
       "                                               title  \\\n",
       "0  Angiotensin-converting enzyme 2 (ACE2) as a SA...   \n",
       "1  Comparative genetic analysis of the novel coro...   \n",
       "2  Incubation Period and Other Epidemiological Ch...   \n",
       "3  Characteristics of and Public Health Responses...   \n",
       "4       Imaging changes in severe COVID-19 pneumonia   \n",
       "\n",
       "                          doi pmcid   pubmed_id   license  \\\n",
       "0  10.1007/s00134-020-05985-9   NaN  32125455.0  cc-by-nc   \n",
       "1   10.1038/s41421-020-0147-1   NaN         NaN     cc-by   \n",
       "2          10.3390/jcm9020538   NaN         NaN     cc-by   \n",
       "3          10.3390/jcm9020575   NaN  32093211.0     cc-by   \n",
       "4  10.1007/s00134-020-05976-w   NaN  32125453.0  cc-by-nc   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0                                                NaN         2020   \n",
       "1                                                NaN         2020   \n",
       "2  The geographic spread of 2019 novel coronaviru...         2020   \n",
       "3  In December 2019, cases of unidentified pneumo...         2020   \n",
       "4                                                NaN         2020   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Zhang, Haibo; Penninger, Josef M.; Li, Yimin; ...   \n",
       "1  Cao, Yanan; Li, Lin; Feng, Zhimin; Wan, Shengq...   \n",
       "2  Linton, M. Natalie; Kobayashi, Tetsuro; Yang, ...   \n",
       "3                   Deng, Sheng-Qun; Peng, Hong-Juan   \n",
       "4                                         Zhang, Wei   \n",
       "\n",
       "                        journal  Microsoft Academic Paper ID WHO #Covidence  \\\n",
       "0            Intensive Care Med                 2.002765e+09          #3252   \n",
       "1                Cell Discovery                 3.003431e+09          #1861   \n",
       "2  Journal of Clinical Medicine                 3.006065e+09          #1043   \n",
       "3                    J Clin Med                 1.776631e+08          #1999   \n",
       "4            Intensive Care Med                 3.006643e+09          #3242   \n",
       "\n",
       "  has_full_text                                     clean_abstract  \n",
       "0          True                                                NaN  \n",
       "1          True                                                NaN  \n",
       "2          True  geograph spread novel coronavirus covid infect...  \n",
       "3          True  decemb case unidentifi pneumonia histori expos...  \n",
       "4         False                                                NaN  "
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metaDataPath = \"~/Downloads/2020-03-13/all_sources_metadata_2020-03-13_clean.csv\"\n",
    "metaData = pd.read_csv(metaDataPath, header = 0)\n",
    "metaData.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "metaData = metaData[metaData[\"clean_abstract\"].notnull()]\n",
    "metaData = metaData[metaData[\"clean_abstract\"].str.contains(\"|\".join([\"coron\", \"covid\"]))]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Load the tf-idf vectorizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "vectPath = \"../../../Downloads/2020-03-13/tf-idf_vectorizer.pkl\"\n",
    "with open(vectPath, 'rb') as vectFile:\n",
    "    vectorizer = pickle.load(vectFile)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Transfer abstracts to document-term matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "docTermMatrix = vectorizer.transform(metaData[\"clean_abstract\"][metaData[\"clean_abstract\"].notnull()]).toarray()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Queries for tasks\n",
    "We allow multiple queries for each task. The top relevant articles and sentences will be retrieved for each query. Below we give the example queries we used for each task. One may choose to run any one of them as the target queries or write new queries (in the form of a list of strings). Here we show the results of running the queries for task 1. At the end of the notebook, we provide a mixed short-cut for the results we got for all tasks."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 1: What is known about transmission, incubation, and environmental stability?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Range of incubation periods for the disease in humans (and how this varies across age and health status) and how long individuals are contagious, even after recovery.\",\n",
    "    \"Prevalence of asymptomatic shedding and transmission (e.g., particularly children).\",\n",
    "    \"Seasonality of transmission.\",\n",
    "    \"Physical science of the coronavirus (e.g., charge distribution, adhesion to hydrophilic/phobic surfaces, environmental survival to inform decontamination efforts for affected areas and provide information about viral shedding).\",\n",
    "    \"Persistence and stability on a multitude of substrates and sources (e.g., nasal discharge, sputum, urine, fecal matter, blood).\",\n",
    "    \"Persistence of virus on surfaces of different materials (e,g., copper, stainless steel, plastic).\",\n",
    "    \"Natural history of the virus and shedding of it from an infected person\",\n",
    "    \"Implementation of diagnostics and products to improve clinical processes\",\n",
    "    \"Disease models, including animal models for infection, disease and transmission\",\n",
    "    \"Tools and studies to monitor phenotypic change and potential adaptation of the virus\",\n",
    "    \"Immune response and immunity\",\n",
    "    \"Effectiveness of movement control strategies to prevent secondary transmission in health care and community settings\",\n",
    "    \"Effectiveness of personal protective equipment (PPE) and its usefulness to reduce risk of transmission in health care and community settings\",\n",
    "    \"Role of the environment in transmission\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 2: What do we know about COVID-19 risk factors?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Smoking, pre-existing pulmonary disease\",\n",
    "    \"Co-infections (determine whether co-existing respiratory/viral infections make the virus more transmissible or virulent) and other co-morbidities\",\n",
    "    \"Neonates and pregnant women\",\n",
    "    \"Socio-economic and behavioral factors to understand the economic impact of the virus and whether there were differences.\",\n",
    "    \"Transmission dynamics of the virus, including the basic reproductive number, incubation period, serial interval, modes of transmission and environmental factors\",\n",
    "    \"Severity of disease, including risk of fatality among symptomatic hospitalized patients, and high-risk patient groups\",\n",
    "    \"Susceptibility of populations\",\n",
    "    \"Public health mitigation measures that could be effective for control\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 3: What do we know about virus genetics, origin, and evolution?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Real-time tracking of whole genomes and a mechanism for coordinating the rapid dissemination of that information to inform the development of diagnostics and therapeutics and to track variations of the virus over time.\",\n",
    "    \"Access to geographic and temporal diverse sample sets to understand geographic distribution and genomic differences, and determine whether there is more than one strain in circulation. Multi-lateral agreements such as the Nagoya Protocol could be leveraged.\",\n",
    "    \"Evidence that livestock could be infected (e.g., field surveillance, genetic sequencing, receptor binding) and serve as a reservoir after the epidemic appears to be over.\",\n",
    "    \"Evidence of whether farmers are infected, and whether farmers could have played a role in the origin.\",\n",
    "    \"Surveillance of mixed wildlife- livestock farms for SARS-CoV-2 and other coronaviruses in Southeast Asia.\",\n",
    "    \"Experimental infections to test host range for this pathogen.\",\n",
    "    \"Animal host(s) and any evidence of continued spill-over to humans\",\n",
    "    \"Socioeconomic and behavioral risk factors for this spill-over\",\n",
    "    \"Sustainable risk reduction strategies\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 4: What do we know about vaccines and therapeutics?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Effectiveness of drugs being developed and tried to treat COVID-19 patients.\",\n",
    "    \"Clinical and bench trials to investigate less common viral inhibitors against COVID-19 such as naproxen, clarithromycin, and minocyclinethat that may exert effects on viral replication.\",\n",
    "    \"Methods evaluating potential complication of Antibody-Dependent Enhancement (ADE) in vaccine recipients.\",\n",
    "    \"Exploration of use of best animal models and their predictive value for a human vaccine.\",\n",
    "    \"Capabilities to discover a therapeutic (not vaccine) for the disease, and clinical effectiveness studies to discover therapeutics, to include antiviral agents.\",\n",
    "    \"Alternative models to aid decision makers in determining how to prioritize and distribute scarce, newly proven therapeutics as production ramps up. This could include identifying approaches for expanding production capacity to ensure equitable and timely distribution to populations in need.\",\n",
    "    \"Efforts targeted at a universal coronavirus vaccine.\",\n",
    "    \"Efforts to develop animal models and standardize challenge studies\",\n",
    "    \"Efforts to develop prophylaxis clinical studies and prioritize in healthcare workers\",\n",
    "    \"Approaches to evaluate risk for enhanced disease after vaccination\",\n",
    "    \"Assays to evaluate vaccine immune response and process development for vaccines, alongside suitable animal models in conjunction with therapeutics\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 5: What has been published about medical care?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Resources to support skilled nursing facilities and long term care facilities.\",\n",
    "    \"Mobilization of surge medical staff to address shortages in overwhelmed communities\",\n",
    "    \"Age-adjusted mortality data for Acute Respiratory Distress Syndrome (ARDS) with/without other organ failure  particularly for viral etiologies\",\n",
    "    \"Extracorporeal membrane oxygenation (ECMO) outcomes data of COVID-19 patients\",\n",
    "    \"Outcomes data for COVID-19 after mechanical ventilation adjusted for age.\",\n",
    "    \"Knowledge of the frequency, manifestations, and course of extrapulmonary manifestations of COVID-19, including, but not limited to, possible cardiomyopathy and cardiac arrest.\",\n",
    "    \"Application of regulatory standards (e.g., EUA, CLIA) and ability to adapt care to crisis standards of care level.\",\n",
    "    \"Approaches for encouraging and facilitating the production of elastomeric respirators, which can save thousands of N95 masks.\",\n",
    "    \"Best telemedicine practices, barriers and faciitators, and specific actions to remove/expand them within and across state boundaries.\",\n",
    "    \"Guidance on the simple things people can do at home to take care of sick people and manage disease.\",\n",
    "    \"Oral medications that might potentially work.\",\n",
    "    \"Use of AI in real-time health care delivery to evaluate interventions, risk factors, and outcomes in a way that could not be done manually.\",\n",
    "    \"Best practices and critical challenges and innovative solutions and technologies in hospital flow and organization, workforce protection, workforce allocation, community-based support resources, payment, and supply chain management to enhance capacity, efficiency, and outcomes.\",\n",
    "    \"Efforts to define the natural history of disease to inform clinical care, public health interventions, infection prevention control, transmission, and clinical trials\",\n",
    "    \"Efforts to develop a core clinical outcome set to maximize usability of data across a range of trials\",\n",
    "    \"Efforts to determine adjunctive and supportive interventions that can improve the clinical outcomes of infected patients (e.g. steroids, high flow oxygen)\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 6: What do we know about non-pharmaceutical interventions?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Guidance on ways to scale up NPIs in a more coordinated way (e.g., establish funding, infrastructure and authorities to support real time, authoritative (qualified participants) collaboration with all states to gain consensus on consistent guidance and to mobilize resources to geographic areas where critical shortfalls are identified) to give us time to enhance our health care delivery system capacity to respond to an increase in cases.\",\n",
    "    \"Rapid design and execution of experiments to examine and compare NPIs currently being implemented. DHS Centers for Excellence could potentially be leveraged to conduct these experiments.\",\n",
    "    \"Rapid assessment of the likely efficacy of school closures, travel bans, bans on mass gatherings of various sizes, and other social distancing approaches.\",\n",
    "    \"Methods to control the spread in communities, barriers to compliance and how these vary among different populations.\",\n",
    "    \"Models of potential interventions to predict costs and benefits that take account of such factors as race, income, disability, age, geographic location, immigration status, housing status, employment status, and health insurance status.\",\n",
    "    \"Policy changes necessary to enable the compliance of individuals with limited resources and the underserved with NPIs.\",\n",
    "    \"Research on why people fail to comply with public health advice, even if they want to do so (e.g., social or financial costs may be too high).\",\n",
    "    \"Research on the economic impact of this or any pandemic. This would include identifying policy and programmatic alternatives that lessen/mitigate risks to critical government services, food distribution and supplies, access to critical household supplies, and access to health diagnoses, treatment, and needed care, regardless of ability to pay.\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 7: Sample task with sample submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Are there geographic variations in the rate of COVID-19 spread?\",\n",
    "    \"Are there geographic variations in the mortality rate of COVID-19?\",\n",
    "    \"there any evidence to suggest geographic based virus mutations?\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 8: What do we know about diagnostics and surveillance?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"How widespread current exposure is to be able to make immediate policy recommendations on mitigation measures. Denominators for testing and a mechanism for rapidly sharing that information, including demographics, to the extent possible. Sampling methods to determine asymptomatic disease (e.g., use of serosurveys (such as convalescent samples) and early detection of disease (e.g., use of screening of neutralizing antibodies such as ELISAs).\",\n",
    "    \"Efforts to increase capacity on existing diagnostic platforms and tap into existing surveillance platforms.\",\n",
    "    \"Recruitment, support, and coordination of local expertise and capacity (public, privatecommercial, and non-profit, including academic), including legal, ethical, communications, and operational issues.\",\n",
    "    \"National guidance and guidelines about best practices to states (e.g., how states might leverage universities and private laboratories for testing purposes, communications to public health officials and the public).\",\n",
    "    \"Development of a point-of-care test (like a rapid influenza test) and rapid bed-side tests, recognizing the tradeoffs between speed, accessibility, and accuracy.\",\n",
    "    \"Rapid design and execution of targeted surveillance experiments calling for all potential testers using PCR in a defined area to start testing and report to a specific entity. These experiments could aid in collecting longitudinal samples, which are critical to understanding the impact of ad hoc local interventions (which also need to be recorded).\",\n",
    "    \"Separation of assay development issues from instruments, and the role of the private sector to help quickly migrate assays onto those devices.\",\n",
    "    \"Efforts to track the evolution of the virus (i.e., genetic drift or mutations) and avoid locking into specific reagents and surveillance/detection schemes.\",\n",
    "    \"Latency issues and when there is sufficient viral load to detect the pathogen, and understanding of what is needed in terms of biological and environmental sampling.\",\n",
    "    \"Use of diagnostics such as host response markers (e.g., cytokines) to detect early disease or predict severe disease progression, which would be important to understanding best clinical practice and efficacy of therapeutic interventions.\",\n",
    "    \"Policies and protocols for screening and testing.\",\n",
    "    \"Policies to mitigate the effects on supplies associated with mass testing, including swabs and reagents.\",\n",
    "    \"Technology roadmap for diagnostics.\",\n",
    "    \"Barriers to developing and scaling up new diagnostic tests (e.g., market forces), how future coalition and accelerator models (e.g., Coalition for Epidemic Preparedness Innovations) could provide critical funding for diagnostics, and opportunities for a streamlined regulatory environment.\",\n",
    "    \"New platforms and technology (e.g., CRISPR) to improve response times and employ more holistic approaches to COVID-19 and future diseases.\",\n",
    "    \"Coupling genomics and diagnostic testing on a large scale.\",\n",
    "    \"Enhance capabilities for rapid sequencing and bioinformatics to target regions of the genome that will allow specificity for a particular variant.\",\n",
    "    \"Enhance capacity (people, technology, data) for sequencing with advanced analytics for unknown pathogens, and explore capabilities for distinguishing naturally-occurring pathogens from intentional.\",\n",
    "    \"One Health surveillance of humans and potential sources of future spillover or ongoing exposure for this organism and future pathogens, including both evolutionary hosts (e.g., bats) and transmission hosts (e.g., heavily trafficked and farmed wildlife and domestic food and companion species), inclusive of environmental, demographic, and occupational risk factors.\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 9: What has been published about ethical and social science considerations?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Efforts to articulate and translate existing ethical principles and standards to salient issues in COVID-2019\",\n",
    "    \"Efforts to embed ethics across all thematic areas, engage with novel ethical issues that arise and coordinate to minimize duplication of oversight\",\n",
    "    \"Efforts to support sustained education, access, and capacity building in the area of ethics\",\n",
    "    \"Efforts to establish a team at WHO that will be integrated within multidisciplinary research and operational platforms and that will connect with existing and expanded global networks of social sciences.\",\n",
    "    \"Efforts to develop qualitative assessment frameworks to systematically collect information related to local barriers and enablers for the uptake and adherence to public health measures for prevention and control. This includes the rapid identification of the secondary impacts of these measures. (e.g. use of surgical masks, modification of health seeking behaviors for SRH, school closures)\",\n",
    "    \"Efforts to identify how the burden of responding to the outbreak and implementing public health measures affects the physical and psychological health of those providing care for Covid-19 patients and identify the immediate needs that must be addressed.\",\n",
    "    \"Efforts to identify the underlying drivers of fear, anxiety and stigma that fuel misinformation and rumor, particularly through social media.\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 10: What has been published about information sharing and inter-sectoral collaboration?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries = [\n",
    "    \"Methods for coordinating data-gathering with standardized nomenclature.\",\n",
    "    \"Sharing response information among planners, providers, and others.\",\n",
    "    \"Understanding and mitigating barriers to information-sharing.\",\n",
    "    \"How to recruit, support, and coordinate local (non-Federal) expertise and capacity relevant to public health emergency response (public, private, commercial and non-profit, including academic).\",\n",
    "    \"Integration of federal/state/local public health surveillance systems.\",\n",
    "    \"Value of investments in baseline public health response infrastructure preparedness\",\n",
    "    \"Modes of communicating with target high-risk populations (elderly, health care workers).\",\n",
    "    \"Risk communication and guidelines that are easy to understand and follow (include targeting at risk populations families too).\",\n",
    "    \"Communication that indicates potential risk of disease to all population groups.\",\n",
    "    \"Misunderstanding around containment and mitigation.\",\n",
    "    \"Action plan to mitigate gaps and problems of inequity in the Nations public health capability, capacity, and funding to ensure all citizens in need are supported and can access information, surveillance, and treatment.\",\n",
    "    \"Measures to reach marginalized and disadvantaged populations.Data systems and research priorities and agendas incorporate attention to the needs and circumstances of disadvantaged populations and underrepresented minorities.\",\n",
    "    \"Mitigating threats to incarcerated people from COVID-19, assuring access to information, prevention, diagnosis, and treatment.\",\n",
    "    \"Understanding coverage policies (barriers and opportunities) related to testing, treatment, and care\"\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Transfer queries to query-term matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {},
   "outputs": [],
   "source": [
    "normQueries = [textNormalize(q) for q in queries] # Text normalization for all queries\n",
    "queryTermMatrix = vectorizer.transform(normQueries).toarray()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Level 1: retrieve top related articles based on cosine similarity between tf-idf vectors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Compute cosine similarity between each query and all abstracts."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time spent: 1.822s.\n"
     ]
    }
   ],
   "source": [
    "startTime = time.time()\n",
    "queryDocDist = 1 - cdist(queryTermMatrix, docTermMatrix, metric = 'cosine')\n",
    "print(\"Time spent: \" + str(round((time.time() - startTime), 3)) + \"s.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [],
   "source": [
    "def retrieveTopLiter(queries, queryDocDist, outputPath, nDoc = 5, showResults = True):\n",
    "    \"\"\"\n",
    "    Function to retrieve the top n literatures for each query based on cosine similarities between query tf-idf \n",
    "    representations and literature tf-idf representations. \n",
    "    Input:\n",
    "        queries: a list of m strings where each string is a text normalized query.\n",
    "        queryDocDist: a m x n array that gives the pairwise cosine similarity between the m queries and n literatures.\n",
    "        outputPath: a string specifies the path to the output file.\n",
    "        nDoc (default 5): the number of literatures to be retrieved for each query.\n",
    "        showResults (default True): whether show the results in the terminal.\n",
    "    Output:\n",
    "        The abstract and metadata of the retrieved literatures will be written to the output file specified by\n",
    "        outputPath.\n",
    "    \"\"\"\n",
    "    outputFile = open(outputPath, \"w\")\n",
    "    for i in range(len(queries)):\n",
    "        print(\"Query: \", queries[i])\n",
    "        print(\"\")\n",
    "        outputFile.write(\"Query: \" + queries[i] + \"\\n\\n\")\n",
    "        docCount = 1\n",
    "        for idx in queryDocDist[i].argsort()[-nDoc:][::-1]:\n",
    "            docMeta = metaData[metaData[\"abstract\"].notnull()].iloc[idx]\n",
    "            if showResults:\n",
    "                print(\"#\" + str(docCount) + \" article\")\n",
    "                print(\"Cosine similarity: \", queryDocDist[i][idx])\n",
    "                print(\"PMC_ID: \", docMeta[\"pmcid\"])\n",
    "                print(\"Title: \", docMeta[\"title\"])\n",
    "                print(\"Abstract: \", docMeta[\"abstract\"])\n",
    "                print(\"Has full text: \", docMeta[\"has_full_text\"])\n",
    "                print(\"\")\n",
    "            \n",
    "            outputFile.write(\"#\" + str(docCount) + \" article\\n\")\n",
    "            outputFile.write(\"Cosine similarity: \" + str(round(queryDocDist[i][idx], 5)) + \"\\n\")\n",
    "            outputFile.write(\"PMC_ID: \" + str(docMeta[\"pmcid\"]) + \"\\n\")\n",
    "            outputFile.write(\"Title: \" + docMeta[\"title\"] + \"\\n\")\n",
    "            outputFile.write(\"Abstract: \" + docMeta[\"abstract\"] + \"\\n\")\n",
    "            outputFile.write(\"Has full text: \" + str(docMeta[\"has_full_text\"]) + \"\\n\\n\")\n",
    "            \n",
    "            docCount += 1\n",
    "    outputFile.close()\n",
    "    return"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "List out the meta information for top 5 related articles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Query:  Resources to support skilled nursing facilities and long term care facilities.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.2723194826605144\n",
      "PMC_ID:  PMC6154147\n",
      "Title:  Severe Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care Facility\n",
      "Abstract:  We describe an outbreak of severe respiratory illness associated with human coronavirus NL63 in a long-term care facility in Louisiana in November 2017. Six of 20 case-patients were hospitalized with pneumonia, and 3 of 20 died. Clinicians should consider human coronavirus NL63 for patients in similar settings with respiratory disease.\n",
      "Has full text:  True\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.2683122465516524\n",
      "PMC_ID:  PMC2870246\n",
      "Title:  Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-care facilities in Melbourne, Australia.\n",
      "Abstract:  Three outbreaks of respiratory illness associated with human coronavirus HCoV-OC43 infection occurred in geographically unrelated aged-care facilities in Melbourne, Australia during August and September 2002. On clinical and epidemiological grounds the outbreaks were first thought to be caused by influenza virus. HCoV-OC43 was detected by RT-PCR in 16 out of 27 (59%) specimens and was the only virus detected at the time of sampling. Common clinical manifestations were cough (74%), rhinorrhoea (59%) and sore throat (53%). Attack rates and symptoms were similar in residents and staff across the facilities. HCoV-OC43 was also detected in surveillance and diagnostic respiratory samples in the same months. These outbreaks establish this virus as a cause of morbidity in aged-care facilities and add to increasing evidence of the significance of coronavirus infections.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.2235867224272814\n",
      "PMC_ID:  PMC4630490\n",
      "Title:  Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015\n",
      "Abstract:  Since the first imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection was reported on May 20, 2015 in Korea, there have been 186 laboratory-confirmed cases of MERS-CoV infection with 36 fatalities. Ninety-seven percent (181/186) of the cases had exposure to the health care facilities. We are reporting a superspreading event that transmitted MERS-CoV to 81 persons at a hospital emergency room (ER) during the Korean outbreak in 2015. The index case was a 35-yr-old man who had vigorous coughing while staying at the ER for 58 hr. As in severe acute respiratory syndrome outbreaks, superspreading events can cause a large outbreak of MERS in healthcare facilities with severe consequences. All healthcare facilities should establish and implement infection prevention and control measure as well as triage policies and procedures for early detection and isolation of suspected MERS-CoV cases.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.18461132851075868\n",
      "PMC_ID:  nan\n",
      "Title:  Global challenges in health and health care for nurses and midwives everywhere\n",
      "Abstract:  The next decade is likely to produce any number of global challenges that will affect health and health care, including pan-national infections such as the new coronavirus COVID-19 and others that will be related to global warming. Nurses will be required to react to these events, even though they will also be affected as ordinary citizens. The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.17935256319242465\n",
      "PMC_ID:  nan\n",
      "Title:  Nursing human resource management of infectious disease hospitals under novel coronavirus pneumonia threats\n",
      "Abstract:  With the outbreak of novel coronavirus pneumonia, Beijing You'an Hospital has become one of the three infectious disease specialist hospitals designated to treat patients of such pneumonia. Under the premise of comprehensively implementing various emergency treatment tasks and ensuring the normal operation of other wards, the Nursing Department has put in place emergency plans and deployed due manpower for rapid response, timely personnel deployment, and reasonable reserve echelon structure. These measures have been taken as required by the patients&rsquo; numbers, critical conditions, disease diagnosis, and the guidelines of treatment and protection. While ensuring the completion of treatment work, we manage to leverage nursing human resources in a scientific, standardized and maximized efficiency manner, to ensure the quality of nursing, and the physical and mental health of nursing staff.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Mobilization of surge medical staff to address shortages in overwhelmed communities\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.19250634434175018\n",
      "PMC_ID:  nan\n",
      "Title:  Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19\n",
      "Abstract:  Objective: To investigate the mental health of clinical first-line medical staff in COVID-19 epidemic and provide theoretical basis for psychological intervention. Method: The mental health status of the first-line medical staff was investigated by Self-rating Anxiety Acale (SAS) and Post-Traumatic Stress Disorder Self-rating Scale(PTSD-SS). From February 7 to 14, 2020, 246 medical staff were investigated who participated in the treatment of COVID-19 using cluster sampling , and received 230 responses, with a recovery rate of 93.5%. Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91  10.89). Among them, the incidence of severe anxiety, moderate anxiety and mild anxiety were 2.17% (5/230), 4.78% (11/230) and 16.09% (37/230), respectively. The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.7811.12) vs (39.14  9.01), t =-2.548, P=0.012]. The incidence of anxiety in nurses was higher than that in doctors [26.88% (43/160) vs 14.29% (10/70), Z=-2.066, P=0.039], and the score of SAS in nurses was higher than that in doctors [(44.8410.42) vs (38.5010.72), t =-4.207, P<0.001]. The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92  17.88). The score of PTSD-SS in female medical staff was higher than that of male [(44.3018.42) vs(36.91  13.95), t=-2.472, P=0.014]. Conclusions: In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.17487385456860194\n",
      "PMC_ID:  nan\n",
      "Title:  Time to use the p-word? Coronavirus enters dangerous new phase\n",
      "Abstract:  As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic. As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.16536151288195422\n",
      "PMC_ID:  PMC4405869\n",
      "Title:  An educational programme for nursing college staff and students during a MERS- coronavirus outbreak in Saudi Arabia\n",
      "Abstract:  BACKGROUND: The Middle Eastern Respiratory Syndrome Coronavirus is a serious and emerging issue in Saudi Arabia and the world. A response was required to reduce possible disease transmission between the hospital and university. College of Nursing academic staff developed a programme in response to the educational and emotional needs of participants. METHODS: A MERS-CoV Task Force responded to the rapidly unfolding epidemic. The aim was to find out what nursing staff and nursing students in the college knew about MERS- CoV. While most gaps in knowledge were addressed after an intense information seminar, other learning needs were identified and responded to. The Task Force developed mandatory information sessions for all nursing faculty, students and staff. All staff were informed by email, letters and posters. There are 28 faculty staff, 84 support staff and 480 students in the College of Nursing. The information settings all took place within the College of Nursing, Princess Nourah University, Kingdom of Saudi Arabia. Questionnaires were given to faculty, students and staff to understand their baseline knowledge. After the sessions, faculty, students and staff were asked about what was learned through the sessions, and what educational needs still needed to be addressed. Approval was sought and received by the Ethics Committee for the College of Nursing. Participants completed informed consent forms and the voluntary nature of the study was explained. RESULTS: The total number of people attending the education sessions was133, including 65 students. 18 faculty members attended and 57 support staff. Data was gathered on gaps in participant knowledge and a plan was developed to address the gaps. Policies were established around student participation in clinical and return to work practices for staff with any symptoms. CONCLUSION: In hospitals there is above average risk for exposure to infectious diseases. Student nurses travel between hospital and university, with the capacity to act as a conduit of pathogens to large, susceptible populations. Nursing colleges must respond thoroughly to protect students and staff and prevent spread of disease into the university community in the midst of an epidemic.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.15351536200666027\n",
      "PMC_ID:  nan\n",
      "Title:  Advices on the prevention and control of nosocomial infection of novel coronavirus within childrens hospitals\n",
      "Abstract:  The pneumonia caused by the novel coronavirus (2019-nCoV), which began in December 2019, has become the most serious public health problem, threatening people's health and life. This threat is posing a severe challenge on the diagnosis and treatment of 2019-nCoV infection, the prevention and control of hospital cross infection of medical staff. It is suggested that in addition to strengthening the organization and leadership of the abovementioned work, establishing and improving the prevention and control mechanism deserve greater attention. Furthermore, special attention should be given to the safety of the medical staff, strengthening their infection monitoring and outbreak management. Medical staff in different work areas and positions should be placed under careful protection, cleaning and disinfection measures. The protection during specimen collection, transportation and medical waste management should also be prioritized. This paper also put forward management suggestions for the outpatient department, isolation ward and other key departments. These measures are proposed to provide a guidance for the prevention and control of 2019-nCoV nosocomial infection in the pediatric outpatient and ward.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.1514717050450305\n",
      "PMC_ID:  PMC5719735\n",
      "Title:  Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\n",
      "Abstract:  OBJECTIVE: Recognizing increasing interest in community disease surveillance globally, the goal of this study was to investigate whether respiratory viruses circulating in the community may be represented through clinical (hospital) surveillance in Nigeria. RESULTS: Children were selected via convenience sampling from communities and a tertiary care center (n=91) during spring 2017 in Ilorin, Nigeria. Nasal swabs were collected and tested using polymerase chain reaction. The majority (79.1%) of subjects were under 6years old, of whom 46 were infected (63.9%). A total of 33 of the 91 subjects had one or more respiratory tract virus; there were 10 cases of triple infection and 5 of quadruple. Parainfluenza virus 4, respiratory syncytial virus B and enterovirus were the most common viruses in the clinical sample; present in 93.8% (15/16) of clinical subjects, and 6.7% (5/75) of community subjects (significant difference, p<0.001). Coronavirus OC43 was the most common virus detected in community members (13.3%, 10/75). A different strain, Coronavirus OC 229 E/NL63 was detected among subjects from the clinic (2/16) and not detected in the community. This pilot study provides evidence that data from the community can potentially represent different information than that sourced clinically, suggesting the need for community surveillance to enhance public health efforts and scientific understanding of respiratory infections.\n",
      "Has full text:  True\n",
      "\n",
      "Query:  Age-adjusted mortality data for Acute Respiratory Distress Syndrome (ARDS) with/without other organ failure  particularly for viral etiologies\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.27191658049471834\n",
      "PMC_ID:  PMC5578707\n",
      "Title:  A Mouse Model for MERS Coronavirus Induced Acute Respiratory Distress Syndrome\n",
      "Abstract:  Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel virus that emerged in 2012, causing acute respiratory distress syndrome (ARDS), severe pneumonia-like symptoms, and multi-organ failure, with a case fatality rate of ~36%. Limited clinical studies indicate that humans infected with MERS-CoV exhibited pathology consistent with late stages of ARDS, which is reminiscent of disease observed in patients infected with SARS coronavirus. Models of MERS-CoV-induced severe respiratory disease have been difficult to achieve, and small animal models traditionally used to investigate viral pathogenesis (mouse, hamster, guinea pig, and ferret) are naturally resistant to MERS-CoV. Therefore, we used CRISPR/Cas9 to modify the mouse genome to encode two human amino acids (288 and 330) in the dipeptidyl peptidase 4 receptor, making mice susceptible to MERS-CoV replication. Serial MERS-CoV passage in these engineered mice was then used to generate a mouse-adapted virus that replicated efficiently within the lungs, and evoked symptoms indicative of severe acute respiratory distress syndrome (ARDS), including decreased survival, extreme weight loss, decreased pulmonary function, pulmonary hemorrhage, and pathological signs indicative of end stage lung disease. Importantly, therapeutic countermeasures comprising MERS-CoV neutralizing antibody treatment or a MERS-CoV spike protein vaccine protected engineered mice against MERS-CoV-induced ARDS.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.27016541710757025\n",
      "PMC_ID:  PMC2704758\n",
      "Title:  Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection\n",
      "Abstract:  Several respiratory viruses, including influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV), produce more severe disease in the elderly, yet the molecular mechanisms governing age-related susceptibility remain poorly studied. Advanced age was significantly associated with increased SARS-related deaths, primarily due to the onset of early- and late-stage acute respiratory distress syndrome (ARDS) and pulmonary fibrosis. Infection of aged, but not young, mice with recombinant viruses bearing spike glycoproteins derived from early human or palm civet isolates resulted in death accompanied by pathological changes associated with ARDS. In aged mice, a greater number of differentially expressed genes were observed than in young mice, whose responses were significantly delayed. Differences between lethal and nonlethal virus phenotypes in aged mice could be attributed to differences in host response kinetics rather than virus kinetics. SARS-CoV infection induced a range of interferon, cytokine, and pulmonary wound-healing genes, as well as several genes associated with the onset of ARDS. Mice that died also showed unique transcriptional profiles of immune response, apoptosis, cell cycle control, and stress. Cytokines associated with ARDS were significantly upregulated in animals experiencing lung pathology and lethal disease, while the same animals experienced downregulation of the ACE2 receptor. These data suggest that the magnitude and kinetics of a disproportionately strong host innate immune response contributed to severe respiratory stress and lethality. Although the molecular mechanisms governing ARDS pathophysiology remain unknown in aged animals, these studies reveal a strategy for dissecting the genetic pathways by which SARS-CoV infection induces changes in the host response, leading to death.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.2464594901003485\n",
      "PMC_ID:  PMC6805532\n",
      "Title:  Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection\n",
      "Abstract:  BACKGROUND: Mortality is high among patients with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. We aimed to determine hospital mortality and the factors associated with it in a cohort of MERS-CoV patients. METHODS: We reviewed hospital records of confirmed cases (detection of virus by polymerase chain reaction from respiratory tract samples) of MERS-CoV patients (n=63) admitted to Buraidah Central Hospital in Al-Qassim, Saudi Arabia between 2014 and 2017. We abstracted data on demography, vital signs, associated conditions presented on admission, pre-existing chronic diseases, treatment, and vital status. Bi-variate comparisons and multiple logistic regressions were the choice of data analyses. RESULTS: The mean age was 60years (SD=18.2); most patients were male (74.6%) and Saudi citizens (81%). All but two patients were treated with Ribavirin plus Interferon. Hospital mortality was 25.4%. Patients who were admitted with septic shock and/or organ failure were significantly more likely to die than patients who were admitted with pneumonia and/or acute respiratory distress syndrome (OR=47.9, 95% CI=3.9, 585.5, p-value 0.002). Age, sex, and presence of chronic conditions were not significantly associated with mortality. CONCLUSION: Hospital mortality was 25%; septic shock/organ failure at admittance was a significant predictor of mortality.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.23761643345215944\n",
      "PMC_ID:  PMC527336\n",
      "Title:  Initial viral load and the outcomes of SARS\n",
      "Abstract:  BACKGROUND: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus. It may progress to respiratory failure, and a significant proportion of patients die. Preliminary data suggest that a high viral load of the SARS coronavirus is associated with adverse outcomes in the intensive care unit, but the relation of viral load to survival is unclear. METHODS: We prospectively studied an inception cohort of 133 patients with virologically confirmed SARS who were admitted to 2 general acute care hospitals in Hong Kong from Mar. 24 to May 4, 2003. The patients were followed until death or for a minimum of 90 days. We used Cox proportional hazard modelling to analyze potential predictors of survival recorded at the time of presentation, including viral load from nasopharyngeal specimens (measured by quantitative reverse transcriptase polymerase chain reaction [PCR] of the SARS-associated coronavirus). RESULTS: Thirty-two patients (24.1%) met the criteria for acute respiratory distress syndrome, and 24 patients (18.0%) died. The following baseline factors were independently associated with worse survival: older age (6180 years) (adjusted hazard ratio [HR] 5.24, 95% confidence interval [CI] 2.0313.53), presence of an active comorbid condition (adjusted HR 3.36, 95% CI 1.447.82) and higher initial viral load of SARS coronavirus, according to quantitative PCR of nasopharyngeal specimens (adjusted HR 1.21 per log(10) increase in number of RNA copies per millilitre, 95% CI 1.061.39). INTERPRETATION: We found preliminary evidence that higher initial viral load is independently associated with worse prognosis in SARS. Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load. These considerations will be important in future studies of SARS.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.21268418676655965\n",
      "PMC_ID:  PMC4267971\n",
      "Title:  Molecular pathology of emerging coronavirus infections\n",
      "Abstract:  Respiratory viruses can cause a wide spectrum of pulmonary diseases, ranging from mild, upper respiratory tract infections to severe and life-threatening lower respiratory tract infections, including the development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Viral clearance and subsequent recovery from infection require activation of an effective host immune response; however, many immune effector cells may also cause injury to host tissues. Severe acute respiratory syndrome (SARS) coronavirus and Middle East respiratory syndrome (MERS) coronavirus cause severe infection of the lower respiratory tract, with 10% and 35% overall mortality rates, respectively; however, >50% mortality rates are seen in the aged and immunosuppressed populations. While these viruses are susceptible to interferon treatment in vitro, they both encode numerous genes that allow for successful evasion of the host immune system until after high virus titres have been achieved. In this review, we discuss the importance of the innate immune response and the development of lung pathology following human coronavirus infection.\n",
      "Has full text:  True\n",
      "\n",
      "Query:  Extracorporeal membrane oxygenation (ECMO) outcomes data of COVID-19 patients\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.5439439800048819\n",
      "PMC_ID:  nan\n",
      "Title:  Recommendations on extracorporeal life support for critically ill patients with novel coronavirus pneumonia\n",
      "Abstract:  Along with the sharp increase of confirmed cases novel coronavirus infection, more critically ill cases require extracorporeal membrane oxygenation (ECMO) support. Based on the clinical data of novel coronavirus pneumonia (NCP), as well as the dada from previous clinical studies and the recommendations from the Extracorporeal Life Support Organization (ELSO), the committee board of the Chinese Society of Extracorporeal Life Support (CSECLS) made this recommendations to guide clinical ECMO application in the patients with NCP.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.45500886534499196\n",
      "PMC_ID:  PMC5768582\n",
      "Title:  Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus\n",
      "Abstract:  BACKGROUND: Middle East respiratory syndrome (MERS) is caused by a coronavirus (MERSCoV) and is characterized by hypoxemic respiratory failure. The objective of this study is to compare the outcomes of MERS-CoV patients before and after the availability of extracorporeal membrane oxygenation (ECMO) as a rescue therapy in severely hypoxemic patients who failed conventional strategies. METHODS: We collected data retrospectively on MERS-CoV patients with refractory respiratory failure from April 2014 to December 2015 in 5 intensive care units (ICUs) in Saudi Arabia. Patients were classified into two groups: ECMO versus conventional therapy. Our primary outcome was in-hospital mortality; secondary outcomes included ICU and hospital length of stay. RESULTS: Thirty-five patients were included; 17 received ECMO and 18 received conventional therapy. Both groups had similar baseline characteristics. The ECMO group had lower in-hospital mortality (65 vs. 100%, P=0.02), longer ICU stay (median 25 vs. 8days, respectively, P<0.01), and similar hospital stay (median 41 vs. 31days, P=0.421). In addition, patients in the ECMO group had better PaO2/FiO2 at days 7 and 14 of admission to the ICU (124 vs. 63, and 138 vs. 36, P<0.05), and less use of norepinephrine at days 1 and 14 (29 vs. 80%; and 36 vs. 93%, P<0.05). CONCLUSIONS: ECMO use, as a rescue therapy, was associated with lower mortality in MERS patients with refractory hypoxemia. The results of this, largest to date, support the use of ECMO as a rescue therapy in patients with severe MERS-CoV.\n",
      "Has full text:  True\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.19329447859193727\n",
      "PMC_ID:  PMC4945721\n",
      "Title:  Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea\n",
      "Abstract:  BACKGROUND: From May to July 2015, the Republic of Korea experienced the largest outbreak of Middle East respiratory syndrome (MERS) outside the Arabian Peninsula. A total of 186 patients, including 36 deaths, had been diagnosed with MERS-coronavirus (MERS-CoV) infection as of September 30th, 2015. MATERIALS AND METHODS: We obtained information of patients who were confirmed to have MERS-CoV infection. MERS-CoV infection was diagnosed using real-time reverse-transcriptase polymerase chain reaction assay. RESULTS: The median age of the patients was 55 years (range, 16 to 86). A total of 55.4% of the patients had one or more coexisting medical conditions. The most common symptom was fever (95.2%). At admission, leukopenia (42.6%), thrombocytopenia (46.6%), and elevation of aspartate aminotransferase (42.7%) were observed. Pneumonia was detected in 68.3% of patients at admission and developed in 80.8% during the disease course. Antiviral agents were used for 74.7% of patients. Mechanical ventilation, extracorporeal membrane oxygenation, and convalescent serum were employed for 24.5%, 7.1%, and 3.8% of patients, respectively. Older age, presence of coexisting medical conditions including diabetes or chronic lung disease, presence of dyspnea, hypotension, and leukocytosis at admission, and the use of mechanical ventilation were revealed to be independent predictors of death. CONCLUSION: The clinical features of MERS-CoV infection in the Republic of Korea were similar to those of previous outbreaks in the Middle East. However, the overall mortality rate (20.4%) was lower than that in previous reports. Enhanced surveillance and active management of patients during the outbreak may have resulted in improved outcomes.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.1926128143064072\n",
      "PMC_ID:  nan\n",
      "Title:  Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore\n",
      "Abstract:  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China.To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management.Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.Confirmed SARS-CoV-2 infection.Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir.Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.18398649905875475\n",
      "PMC_ID:  nan\n",
      "Title:  Risk of COVID-19 for patients with cancer\n",
      "Abstract:  The authors concluded by use of epidemiological statistics that because the proportion of patients with cancer histories was higher in a cohort with COVID-19 than in the population in China, patients with cancer were more likely to develop COVID-19. They found 18 COVID-19 patients with cancer histories among 1590 COVID-19 patients from 575 hospitals in 31 provincial regions. Of these 16 patients (two of the 18 patients had unknown treatment status), only four had undergone surgery or chemotherapy within the previous month; 12 had recovered from initial cancer treatments (eg, surgery or chemotherapy) and had no obvious immunosuppression. We therefore do not think the COVID-19 infections in the 12 survivors of previous cancers were associated with their cancers. COVID-19 is a highly contagious infection to which everyone, to our knowledge, is susceptible; the most important morbidity factor is exposure to an infection source.2 Furthermore, although the authors indicate that patients with cancer had worse outcomes from COVID-19, they also reported the median age of these patients (631 years) to be significantly higher than for those without cancer (487 years), suggesting that older age is associated with worse COVID-19 outcomes\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Outcomes data for COVID-19 after mechanical ventilation adjusted for age.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.29768744400820135\n",
      "PMC_ID:  nan\n",
      "Title:  Respiratory support for patients with COVID-19 infection\n",
      "Abstract:  As of Feb 27, 2020, coronavirus disease 2019 (COVID-19) has affected 47 countries and territories around the world.1 Xiaobo Yang and colleagues2 described 52 of 710 patients with confirmed COVID-19 admitted to an intensive care unit (ICU) in Wuhan, China. 29 (56%) of 52 patients were given non-invasive ventilation at ICU admission, of whom 22 (76%) required further orotracheal intubation and invasive mechanical ventilation. The ICU mortality rate among those who required non-invasive ventilation was 23 (79%) of 29 and among those who required invasive mechanical ventilation was 19 (86%) of 22.2 Jonathan Chun-Hei Cheung and colleagues3 do not recommend use of a high-flow nasal cannula or non-invasive ventilation until the patient has viral clearance. Supporting the recommendation of the authors, I would like to add some points in relation to the use of high-flow nasal oxygen therapy and non-invasive ventilation in patients with COVID-19 infection: First, although exhaled air dispersion during high-flow nasal oxygen therapy and non-invasive ventilation via different interfaces is restricted, provided that there is a good mask interface fitting,4 not all hospitals around the world have access to such interfaces or enough personal-protective equipment of sufficiently high quality (ie, considered fit-tested particulate respirators, N95 or equivalent, or higher level of protection) for aerosol-generating procedures, and several hospitals do not have a negative pressure isolation room. Of 1688 health-care workers who have become infected with COVID-19, five (03%) have died;5 a sign of the vastly difficult working conditions for health-care workers.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.2512330360464219\n",
      "PMC_ID:  nan\n",
      "Title:  Critical care crisis and some recommendations during the COVID-19 epidemic in China\n",
      "Abstract:  Lack of critical care resource in face of COVID-19 epidemics Based on data reported by the National Health Commission of China, there have been about 2000 new confirmed cases and?>?4000 suspected cases daily over the past week in Wuhan [3]. About 15% of the patients have developed severe pneumonia, and about 6% need noninvasive or invasive ventilatory support. Currently, there are about 1000 patients who need ventilatory support and another 120 new patients daily who require noninvasive or invasive ventilation support in Wuhan city; however, there are only about 600 ICU beds [4]. To address this shortfall, 70 ICU beds were created from general beds and the government quickly transformed three general hospitals to critical care hospitals with a total of about 2500 beds that specialize in patients with severe SARS-CoV-2 pneumonia (equipped with monitors and high-flow nasal cannula, noninvasive ventilator or invasive ventilators). An equally great (or potentially greater) problem is the shortage of trained personnel to treat these critically ill patients. Until the crisis, there were about 300 ICU physicians and 1000 ICU nurses in Wuhan city. By the end of January, more than 600 additional ICU doctors and 1500 ICU nurses were transferred to Wuhan from the rest of China. As well, an additional 3000 staff including infectious disease, respiratory, internal medicine physicians and nurses were transferred to Wuhan by the government. There are logistical issues which make care of the patients difficult. These include donning of personal protective equipment (e.g., gloves, gowns, respiratory and eye protection), lack of instruments and disposables, and shortages of supplemental oxygen. Many severe hypoxemic patients only receive high-flow nasal oxygen (HFNO) or noninvasive mechanical ventilation rather than invasive mechanical ventilation because of intubation delay or lack of mechanical ventilators (especially at early phase). Our preliminary data show that only about 25% of patients who died were intubated and received mechanical ventilation.JO - Intensive Care Medicine\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.24119263823726023\n",
      "PMC_ID:  nan\n",
      "Title:  COVID-19 (Novel Coronavirus 2019) - recent trends\n",
      "Abstract:  The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it should be contained to prevent the global spread. The COVID-19 virus was known earlier as 2019-nCoV. As of 12 February 2020, WHO reported 45,171 cases and 1115 deaths related to COVID-19. COVID-19 is similar to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) virus in its pathogenicity, clinical spectrum, and epidemiology. Comparison of the genome sequences of COVID-19, SARS-CoV, and Middle East Respiratory Syndrome coronavirus (MERS-CoV) showed that COVID-19 has a better sequence identity with SARS-CoV compared to MERS CoV. However, the amino acid sequence of COVID-19 differs from other coronaviruses specifically in the regions of 1ab polyprotein and surface glycoprotein or S-protein. Although several animals have been speculated to be a reservoir for COVID-19, no animal reservoir has been already confirmed. COVID-19 causes COVID-19 disease that has similar symptoms as SARS-CoV. Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARS-CoV. The nucleocapsid (N) protein of COVID-19 has nearly 90% amino acid sequence identity with SARS-CoV. The N protein antibodies of SARS-CoV may cross react with COVID-19 but may not provide cross-immunity. In a similar fashion to SARS-CoV, the N protein of COVID-19 may play an important role in suppressing the RNA interference (RNAi) to overcome the host defense. This mini-review aims at investigating the most recent trend of COVID-19.\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.2191299529189803\n",
      "PMC_ID:  PMC3999990\n",
      "Title:  Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses\n",
      "Abstract:  BACKGROUND: Many respiratory viruses disproportionately impact the elderly. Likewise, advanced age correlated with more adverse disease outcomes following severe acute respiratory syndrome coronavirus (SARS-CoV) infection in humans. We used an aged African green monkey SARS-CoV infection model to better understand age-related mechanisms of increased susceptibility to viral respiratory infections. Nonhuman primates are critical translational models for such research given their similarities to humans in immune-ageing as well as lung structure. RESULTS: Significant age- and infection-dependent differences were observed in both systemic and mucosal immune compartments. Peripheral lymphocytes, specifically CD8 T and B cells were significantly lower in aged monkeys pre- and post- SARS-CoV infection, while neutrophil and monocyte numbers were not impacted by age or infection status. Serum proinflammatory cytokines were similar in both age groups, whereas significantly lower levels of IL-1beta, IL-18, IL-6, IL-12 and IL-15 were detected in the lungs of SARS-CoV-infected aged monkeys at either 5 or 10days post infection. Total lung leukocyte numbers and relative frequency of CD8 T cells, B cells, macrophages and dendritic cells were greatly reduced in the aged host during SARS-CoV infection, despite high levels of chemoattractants for many of these cells in the aged lung. Dendritic cells and monocytes/macrophages showed age-dependent differences in activation and chemokine receptor profiles, while the CD8 T cell and B cell responses were significantly reduced in the aged host. In examination of viral titers, significantly higher levels of SARS-CoV were detected in the nasal swabs early, at day 1 post infection, in aged as compared to juvenile monkeys, but virus levels were only slightly higher in aged animals by day 3. Although there was a trend of higher titers in respiratory tissues at day 5 post infection, this did not reach statistical significance and virus was cleared from all animals by day 10, regardless of age. CONCLUSIONS: This study provides unique insight into how several parameters of the systemic and mucosal immune response to SARS-CoV infection are significantly modulated by age. These immune differences may contribute to deficient immune function and the observed trend of higher SARS-CoV replication in aged nonhuman primates.\n",
      "Has full text:  True\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.21757794466792846\n",
      "PMC_ID:  nan\n",
      "Title:  Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia\n",
      "Abstract:  Definite evidence has shown that the novel coronavirus (COVID-19) could be transmitted from person to person, so far more than 1,700 bedside clinicians have been infected. A lot of respiratory treatments for critically ill patients are deemed as high-risk factors for nosocomial transmission, such as intubation, manual ventilation by resuscitator, noninvasive ventilation, high-flow nasal cannula, bronchoscopy examination, suction and patient transportation, etc, due to its high possibility to cause or worsen the spread of the virus. As such, we developed this consensus recommendations on all those high-risk treatments, based on the current evidence as well as the resource limitation in some areas, with the aim to reduce the nosocomial transmission and optimize the treatment for the COVID-19 pneumonia patients. Those recommendations include: (1) Standard prevention and protection, and patient isolation; (2) Patient wearing mask during HFNC treatment; (3) Using dual limb ventilator with filters placed at the ventilator outlets, or using heat-moisture exchanger (HME) instead of heated humidification in single limb ventilator with HME placed between exhalation port and mask; avoid using mask with exhalation port on the mask; (4) Placing filter between resuscitator and mask or artificial airway; (5) For spontaneous breathing patients, placing mask for patients during bronchoscopy examination; for patients receiving noninvasive ventilation, using the special mask with bronchoscopy port to perform bronchoscopy; (6) Using sedation and paralytics during intubation, cuff pressure should be maintained between 25-30 cmH(2)O; (7) In-line suction catheter is recommended and it can be used for one week; (8) Dual-limb heated wire circuits are recommended and only changed with visible soiled; (9. For patients who need breathing support during transportation, placing an HME between ventilator and patient; (10) PSV is recommended for implementing spontaneous breathing trial (SBT), avoid using T-piece to do SBT. When tracheotomy patients are weaned from ventilator, HME should be used, avoid using T-piece or tracheostomy mask. (11) Avoid unnecessary bronchial hygiene therapy; (12) For patients who need aerosol therapy, dry powder inhaler metered dose inhaler with spacer is recommended for spontaneous breathing patients; while vibrating mesh nebulizer is recommended for ventilated patients and additional filter is recommended to be placed at the expiratory port of ventilation during nebulization.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Knowledge of the frequency, manifestations, and course of extrapulmonary manifestations of COVID-19, including, but not limited to, possible cardiomyopathy and cardiac arrest.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.19369813255840185\n",
      "PMC_ID:  PMC484515\n",
      "Title:  Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.\n",
      "Abstract:  OBJECTIVE: To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy. DESIGN: Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease. SETTING: University virology department and transplantation unit. METHODS: Reverse transcriptase-polymerase chain reaction and nucleotide sequence analysis of myocardial RNA and DNA; enterovirus-specific in situ hybridization; enterovirus-specific immunoglobulin M detection. RESULTS: Enterovirus RNA was detected in myocardial tissue from only a small proportion of (five of 75) hearts. However, although enterovirus-specific immunoglobulin M responses were detected in 22 (28%) of 39 controls patients, a significantly higher prevalence was observed among patients with dilated cardiomyopathy (22 (56%) of 39 patients; P < 0.005). All enteroviruses detected in myocardium showed greatest nucleotide sequence homology with coxsackievirus type B3. Detection of enterovirus RNA in myocardium by the polymerase chain reaction and by in situ hybridisation gave comparable results. Other potentially cardiotropic virus genomes, including human cytomegalovirus, influenzaviruses, and coronaviruses were not detected in myocardium. CONCLUSION: This study found that enterovirus-specific immunoglobulin M responses provided the strongest evidence of enterovirus involvement in patients with end-stage dilated cardiomyopathy. However, the high background prevalence of these responses limits their diagnostic value. The finding that enteroviruses detected in myocardium were coxsackievirus type B3 accords with recent findings in patients with acute myocarditis, and indicates that this serotype is the major cardiotropic human enterovirus.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.16834329989563135\n",
      "PMC_ID:  nan\n",
      "Title:  World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)\n",
      "Abstract:  An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December of 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is a betacoronavirus that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 50,580 laboratory-confirmed cases and 1,526 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.16804021028363914\n",
      "PMC_ID:  PMC1888177\n",
      "Title:  Myocardial diseases of animals.\n",
      "Abstract:  In this review we have attempted a comprehensive compilation of the cardiac morphologic changes that occur in spontaneous and experimental myocardial diseases of animals. Our coverage addresses diseases of mammals and birds and includes these diseases found in both domesticated and wild animals. A similar review of the myocardial diseases in this broad range of animal species has not been attempted previously. We have summarized and illustrated the gross, microscopic, and ultrastructural alterations for these myocardial diseases; and, whenever possible, we have reviewed their biochemical pathogenesis. We have arranged the myocardial diseases for presentation and discussion according to an etiologic classification with seven categories. These include a group of idiopathic or primary cardiomyopathies recognized in man (hypertrophic, dilated, and restrictive types) and a large group of secondary cardiomyopathies with known causes, such as inherited tendency; nutritional deficiency; toxicity; physical injury and shock; endocrine disorders, and myocarditides of viral, bacterial, and protozoal causation. Considerable overlap exists between each of the etiologic groups in the spectrum of pathologic alterations seen in the myocardium. These include various degenerative changes, myocyte necrosis, and inflammatory lesions. However, some diseases show rather characteristic myocardial alterations such as vacuolar degeneration in anthracycline cardiotoxicity, myofibrillar lysis in furazolidone cardiotoxicity, calcification in calcinosis of mice, glycogen accumulation in the glycogenoses, lipofuscinosis in cattle, fatty degeneration in erucic acid cardiotoxicity, myofiber disarray in hypertrophic cardiomyopathy, and lymphocytic inflammation with inclusion bodies in canine parvoviral myocarditis. The myocardial diseases represent the largest group in the spectrum of spontaneous cardiac diseases of animals. Pericardial and endocardial diseases and congential cardiac diseases are seen less frequently; and, in contrast to man, coronary artery disease and myocardial ischemia are rather infrequent in animals. The present review shows clearly that the spectrum of myocardial diseases in animals is enlarging and that many newly recognized diseases are emerging and assuming considerable importance. For example, various heritable cardiomyopathies have recently been described in the KK mouse, cattle, and rats. Increasingly recognized myocardial diseases include cardiomyopathies in cats, dogs, and birds; anthracycline cardiotoxicity; furazolidone cardiotoxicity; ionophore cardiotoxicity; myocardial damage associated with central nervous system injuries; myocardial hypertrophy in\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.15467617817964585\n",
      "PMC_ID:  PMC6121263\n",
      "Title:  The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview\n",
      "Abstract:  Since being first described more than 60 years ago, Na,K-ATPase has been extensively studied, while novel concepts about its structure, physiology, and biological roles continue to be elucidated. Cardiac glycosides not only inhibit the pump function of Na,K-ATPase but also activate intracellular signal transduction pathways, which are important in many biological processes. Recently, antiviral effects have been described as a novel feature of Na,K-ATPase inhibition with the use of cardiac glycosides. Cardiac glycosides have been reported to be effective against both DNA viruses such as cytomegalovirus and herpes simplex and RNA viruses such as influenza, chikungunya, coronavirus, and respiratory syncytial virus, among others. Consequently, cardiac glycosides have emerged as potential broad-spectrum antiviral drugs, with the great advantage of targeting cell host proteins, which help to minimize resistance to antiviral treatments, making them a very promising strategy against human viral infections. Here, we review the effect of cardiac glycosides on viral biology and the mechanisms by which these drugs impair the replication of this array of different viruses.\n",
      "Has full text:  True\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.14415725824937475\n",
      "PMC_ID:  nan\n",
      "Title:  CT features of 2019-novel coronovirus pneumonia: SARS and MERS literature review and analysis of CT features of two confirmed 2019-novel coronavirus pneumonia cases\n",
      "Abstract:  Objective To analyze the CT manifestations of the 2019 novel coronavirus pneumonia (NCP) combined with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) literature review, and to summarize the characteristics of CT imaging, so as to improve the ability of rapid and accurate diagnosis. Methods CT manifestations of two confirmed cases of NCP were reported, meanwhile the literatures on SARS and MERS imaging performance were reviewed and summarized. Results The two cases of NCP were both in acute stage, the CT imaging showed multiple and scattered ground-glass opacity (GGO) in both lungs, which is similar to the CT performance of SARS and MERS in acute stage. Conclusions The CT features of 2019 novel coronavirus pneumonia are similar to SARS and MERS. It has certain characteristics and changes rapidly with the course of the disease. In the acute stage, GGO and paving stone sign were the main manifestations. In the acute phase, GGO and crazy paving are the main manifestations. In the progress stage, the interlobular septal thickening and consolidation appeared. During the absorption period, the lesions disappeared or fibrosis was left behind, with lung structure distortion and bronchiectasis. Lymphadenopathy and hydrothorax were rare.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Application of regulatory standards (e.g., EUA, CLIA) and ability to adapt care to crisis standards of care level.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.1586783929574891\n",
      "PMC_ID:  PMC4932258\n",
      "Title:  Patient and family satisfaction levels in the intensive care unit after elective cardiac surgery: study protocol for a randomised controlled trial of a preoperative patient education intervention\n",
      "Abstract:  INTRODUCTION: Patients and their families are understandably anxious about the risk of complications and unfamiliar experiences following cardiac surgery. Providing information about postoperative care in the intensive care unit (ICU) to patients and families may lead to lower anxiety levels, and increased satisfaction with healthcare. The objectives of this study are to evaluate the effectiveness of preoperative patient education provided for patients undergoing elective cardiac surgery. METHODS AND ANALYSIS: 100 patients undergoing elective coronary artery bypass graft, with or without valve replacement surgery, will be recruited into a 2-group, parallel, superiority, double-blinded randomised controlled trial. Participants will be randomised to either preoperative patient education comprising of a video and ICU tour with standard care (intervention) or standard education (control). The primary outcome measures are the satisfaction levels of patients and family members with ICU care and decision-making in the ICU. The secondary outcome measures are patient anxiety and depression levels before and after surgery. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Joint Chinese University of Hong KongNew Territories East Cluster Clinical Research Ethics Committee (reference number CREC 2015.308). The findings will be presented at conferences and published in peer-reviewed journals. Study participants will receive a 1-page plain language summary of results. TRIAL REGISTRATION NUMBER: ChiCTR-IOR-15006971.\n",
      "Has full text:  True\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.15123051411028676\n",
      "PMC_ID:  nan\n",
      "Title:  Novel coronavirus infection during the 20192020 epidemic: preparing intensive care unitsthe experience in Sichuan Province, China\n",
      "Abstract:  Novel coronavirus infection special intensive care team We set up a special emergency multi-disciplinary intensive care team to discuss the problems that we might encounter and countermeasures. Team members include intensive care unit (ICU) physician, infectious disease physician, nurse, respiratory therapist, nosocomial infection control expert, and administrative staff. We first evaluated the isolation conditions and the capacity of our department to admit a larger number of patients. Second, we specified the protection levels for different types of health care activities. Third, we assigned special work such as patient screening, consultation, and transfer to designated staff to minimize the number of health workers who had contact with patients with nCoV infection.ID - LiaoER -\n",
      "Has full text:  True\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.1502824742267792\n",
      "PMC_ID:  PMC6695009\n",
      "Title:  Case report: Detection of the Middle East respiratory syndrome corona virus (MERS-CoV) in nasal secretions of a dead human\n",
      "Abstract:  The Middle East respiratory syndrome coronavirus (MERS-CoV) has been recognized as a highly pathogenic virus that infects the human respiratory tract and has high morbidity and mortality. The MERS-CoV is a huge burden on Saudi Arabian health-care facilities, causing approximately 40% mortality. The transmission mechanism of the virus is still not well understood. Therefore, the prevention of any route of transmission is the best measure to arrest the spread of this disease. Using the real time polymerase chain reaction (RT-PCR), MERS-CoV was detected in the nasal secretions of a human cadaver. Full precautions should be applied and carefully followed to prevent the transmission of the virus, especially among health care workers.\n",
      "Has full text:  False\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.13101338315404987\n",
      "PMC_ID:  nan\n",
      "Title:  Potential association between COVID-19 mortality and health-care resource availability\n",
      "Abstract:  As recorded by the Chinese Center for Disease Control and Prevention (China CDC), by Feb 16, 2020, there had been 70641 confirmed cases and 1772 deaths due to COVID-19, with an average mortality of about 25%. However, in-depth analysis of these data show clear disparities in mortality rates between Wuhan (>3%), different regions of Hubei (about 29% on average), and across the other provinces of China (about 07% on average). We postulate that this is likely to be related to the rapid escalation in the number of infections around the epicentre of the outbreak, which has resulted in an insufficiency of health-care resources, thereby negatively affecting patient outcomes in Hubei, while this has not yet been the situation for the other parts of China (figure A, B). If we assume that average levels of health care are similar throughout China, higher numbers of infections in a given population can be considered an indirect indicator of a heavier health-care burden. Plotting mortality against the incidence of COVID-19 (cumulative number of confirmed cases since the start of the outbreak, per 10000 population) showed a significant positive correlation (figure C), suggesting that mortality is correlated with health-care burden.\n",
      "Has full text:  False\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.12851900379963277\n",
      "PMC_ID:  PMC3322746\n",
      "Title:  Severe Acute Respiratory Syndromeassociated Coronavirus in Lung Tissue\n",
      "Abstract:  Efforts to contain severe acute respiratory syndrome (SARS) have been limited by the lack of a standardized, sensitive, and specific test for SARS-associated coronavirus (CoV). We used a standardized reverse transcription-polymerase chain reaction assay to detect SARS-CoV in lung samples obtained from well-characterized patients who died of SARS and from those who died of other reasons. SARS-CoV was detected in all 22 postmortem lung tissues (to 10(9) viral copies/g) from 11 patients with probable SARS but was not detected in any of the 23 lung control samples (sample analysis was blinded). The sensitivity and specificity (95% confidence interval) were 100% (84.6% to 100%) and 100% (85.1% to 100%), respectively. Viral loads were significantly associated with a shorter course of illness but not with the use of ribavirin or steroids. CoV was consistently identified in the lungs of all patients who died of SARS but not in control patients, supporting a primary role for CoV in deaths.\n",
      "Has full text:  True\n",
      "\n",
      "Query:  Approaches for encouraging and facilitating the production of elastomeric respirators, which can save thousands of N95 masks.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.19244128914686742\n",
      "PMC_ID:  nan\n",
      "Title:  Mass masking in the COVID-19 epidemic: people need guidance\n",
      "Abstract:  WHO recommends against wearing masks in community settings because of lack of evidence.2 However, absence of evidence of effectiveness should not be equated to evidence of ineffectiveness, especially when facing a novel situation with limited alternative options. It has long been recommended that for respiratory infections like influenza, affected patients should wear masks to limit droplet spread. If everyone puts on a mask in public places, it would help to remove stigmatisation that has hitherto discouraged masking of symptomatic patients in many places.3 Furthermore, transmission from asymptomatic infected individuals has been documented for COVID-19, and viral load is particularly high at early disease stage.4 , 5 Masking, as a public health intervention, would probably intercept the transmission link and prevent these apparently healthy infectious sources.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.1485863895820262\n",
      "PMC_ID:  PMC6490128\n",
      "Title:  Autopsy Biosafety: Recommendations for Prevention of Meningococcal Disease\n",
      "Abstract:  INTRODUCTION: As invasive meningococcal disease progresses rapidly, often affects youth, and has a fairly high mortality rate, such cases are likely to fall under medical examiner/coroner (ME/C) jurisdiction. Morgue personnel may be at risk of contracting secondary meningococcal disease. We review the current scientific literature regarding Neisseria meningitidis infection and provide recommendations for the prevention of meningococcal disease at autopsy. METHODS: A PubMed search utilizing applicable medical subject heading terms was performed retrieving articles for review from the preceding two decades. Pertinent current guidelines from multiple national organizations were also retrieved. RESULTS: Invasive meningococcal disease is transmitted by direct contact with large respiratory droplets or oral secretions. While a surgical mask would normally provide adequate protection from large droplet spread, it does not prevent inhalation of smaller aerosolized particles such as those generated at autopsy. Prosectors are advised to routinely wear N-95 respirator masks or powered respirator hoods. All published cases of secondary meningococcal disease transmission to healthcare workers invariably arose in scenarios in which face masks/respirators were not employed; none of these cases involved meningococcal disease transmission to ME/C or other morgue staff. DISCUSSION: In the event that no maskor inadequate coverage such as a surgical maskis employed during autopsy of a decedent suspected/confirmed to have invasive meningococcal disease, antibiotic prophylaxis is advisable. Assuming appropriate personal protective equipment is utilized, chemoprophylaxis is unnecessary. Routine meningococcal vaccination is not recommended, except for ME/C with specified immunocompromising conditions or traveling to hyperendemic/endemic meningococcal regions. Acad Forensic Pathol. 2018 8(2): 328-339\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.14120759226949586\n",
      "PMC_ID:  nan\n",
      "Title:  Coronavirus latest: death toll passes 2,000\n",
      "Abstract:  Updates on the respiratory illness that has infected tens of thousands of people. Scientists are concerned about a new virus that has infected tens of thousands of people and killed more than 2,000. The virus, which emerged in the Chinese city of Wuhan in December, is a coronavirus and belongs to the same family as the pathogen that causes severe acute respiratory syndrome, or SARS. It causes a respiratory illness called COVID-19, which can spread from person to person.\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.12546784848184067\n",
      "PMC_ID:  nan\n",
      "Title:  Coronavirus latest: children are as susceptible as adults, study suggests\n",
      "Abstract:  Updates on the respiratory illness that has infected tens of thousands of people and killed thousands. Children are just as likely to get infected with the new coronavirus as adults, finds one of the most detailed studies yet published on the spread of the virus, known as SARS-CoV-2. The analysis  based on data from Shenzhen, China  provides a partial answer to one of the most pressing questions surrounding the outbreak: the role of children.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.12416724690934733\n",
      "PMC_ID:  nan\n",
      "Title:  Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks\n",
      "Abstract:  Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Best telemedicine practices, barriers and faciitators, and specific actions to remove/expand them within and across state boundaries.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.14390381722187784\n",
      "PMC_ID:  nan\n",
      "Title:  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020\n",
      "Abstract:  An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.12698975594944673\n",
      "PMC_ID:  nan\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Title:  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak  United States, February 24, 2020 | MMWR\n",
      "Abstract:  Fourteen cases have been diagnosed in the United States, in addition to 39 cases among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. U.S. government agencies and public health partners are implementing aggressive measures to slow and try to contain transmission of COVID-19 in the United States.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.1140373939216145\n",
      "PMC_ID:  nan\n",
      "Title:  Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020\n",
      "Abstract:  On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.() On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.() Also on January 31, the president of the United States signed a \"Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,\" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.11188920056390328\n",
      "PMC_ID:  nan\n",
      "Title:  Functional assessment of cell entry and receptor usage for lineage B -coronaviruses, including 2019-nCoV\n",
      "Abstract:  Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS- CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these novel viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent 2019-nCoV, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells and confirm that human ACE2 is the receptor for the recently emerging 2019-nCoV.\n",
      "Has full text:  True\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.11099779535982002\n",
      "PMC_ID:  nan\n",
      "Title:  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses\n",
      "Abstract:  Over the past 20years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Guidance on the simple things people can do at home to take care of sick people and manage disease.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.21102536486185053\n",
      "PMC_ID:  nan\n",
      "Title:  Coronavirus latest: deaths in China surpass SARS toll\n",
      "Abstract:  Updates on the respiratory illness that has infected tens of thousands of people. Updates on the respiratory illness that has infected tens of thousands of people. Heres the latest news on the outbreak. 10 February 04:30 GMT  Deaths in China surpass toll from SARS More than 900 people in China have died from the new virus, a greater number than those who died from severe acute respiratory syndrome (SARS) in the 200203 epidemic. That outbreak, which also originated in China, killed 774 people worldwide. The number of people in the country infected with the new coronavirus has risen to 40,171, according to the latest update from Chinas National Health Commission.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.19775474843820073\n",
      "PMC_ID:  nan\n",
      "Title:  Clinical research progresss of antiviral drugs for the novel coronavirus pneumonia\n",
      "Abstract:  The novel coronavirus (2019-nCoV or SARS-CoV-2) is a highly contagious and deadly virus that has infected more than 50 000 people and killed more than 1 000 people in 25 countries around the world. People who infected by the novel coronavirus may suffer from fever and cough, some may gradually appear breathing difficulties and other serious manifestations, some severe patients may have acute respiratory distress syndrome and septic shock leading to death. However, there are no definite and effective antiviral drugs for the novel coronavirus pneumonia all around the world. Therefore, this article aims to provide new idea for the effective treatment of the novel coronavirus pneumonia by summarizing the basic research and clinical progress of antiviral drugs at home and abroad.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.19534048210965982\n",
      "PMC_ID:  nan\n",
      "Title:  Coronavirus: Wales tests 90% of suspected patients in their own home\n",
      "Abstract:  Wales has managed to test 90% of people suspected of being infected with novel coronavirus in their own homes, after implementing community testing for covid-19.Vaughan Gething, minister for health and social services in Wales, credited the NHS with making the process as convenient as possible for people whilst also protecting our ambulance and hospital resources for those who need it most.More than 100 people had been tested in Wales as of 13 February, with no positive cases. Around the UK, nine \n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.18736663891607253\n",
      "PMC_ID:  nan\n",
      "Title:  Coronavirus disease 2019 (covid-19): a guide for UK GPs\n",
      "Abstract:  What you need to knowConsider covid-19 infection in anyone with cough, fever, or breathlessness who has had contact with someone with covid-19, or has returned from a high risk area in the 14 days before the onset of symptomsEvery effort should be made to avoid in-person assessment of patients with possible covid-19 in primary careGP surgeries should plan ahead and develop clear protocols for managing possible cases, including isolation procedures, personal protective equipment, seeking specialist advice, and decontaminationIf covid-19 infection is suspected in someone attending the practice, isolate the patient in a room (away from other patients and staff), close the door, and ask the patient to call NHS 111The guidance may change so it is essential to look at the latest guidance online (box 1)The UK recorded its first confirmed case of acute respiratory infection due to coronavirus disease 2019 (covid-19) on 31 January 2020 and responded by quarantining at-risk individuals to contain the spread of infection. Executive agencies Public Health England (PHE)1 and Health Protection Scotland (HPS) have since published guidance to healthcare providers on managing patients suspected to have the disease.Guidance for the public and health professionals varies internationally, depending partly on risk levels and healthcare systems, and is being regularly updated.This article offers a practical guide for GPs and others working in UK primary care on when to suspect covid-19 and how to respond. It is based on current UK guidance at the time of publication. We recommend readers consult the latest guidance (box 1).Box 1 Essential resourcescovid-19: latest case definition, investigation, and initial clinical management of possible cases:https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infectionCoronavirus: latest information and advice including updated list of high risk countries:https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-publicGuidance on isolation of healthcare workers:https://www.gov.uk/government/publications/novel-coronavirus-2019-ncov-guidance-for-healthcare-providers-with-staff-who-have-travelled-to-china/guidance-for-healthcare-providers-healthcare-workers-who-have-travelled-to-chinaFind your local Health Protection Team in England:https://www.gov.uk/health-protection-teamcovid-19: interim guidance  RETURN TO TEXT\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.17535960188548894\n",
      "PMC_ID:  nan\n",
      "Title:  Scientists question Chinas decision not to report symptom-free coronavirus cases\n",
      "Abstract:  Researchers say that excluding these people could conceal the epidemics true extent, but others say the practice makes sense. Researchers are concerned that Chinas official reports on the number of coronavirus infections have not been including people who have tested positive for the virus but who have no symptoms. They fear the practice is masking the epidemics true scale. But public health experts say China is right to prioritize tracking sick patients who are spreading the disease.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Oral medications that might potentially work.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.29390461379454114\n",
      "PMC_ID:  nan\n",
      "Title:  Psychological intervention in oral patients in novel coronavirus pneumonia outbreak period\n",
      "Abstract:  Public health emergencies have an impact on the public mental health. The outbreak of the novel coronavirus has affected the normal diagnosis and treatment services in oral medical institutions across the country. Delay of non-emergency dental service will have a potential impact on the experience, cognition, treatment and rehabilitation of patients with oral diseases. Through literature review, this paper reviewed the oral psychosomatic diseases closely related to patients' psychological state, such as oral mucosal disease, temporomandibular joint disease, bruxism, periodontal disease and so on. It was believed that these patients might be more susceptible to the impact of stress events, and dental specialists should pay more attention to them. At the same time, this paper analyzes the possible psychological stress symptoms of patients with different oral diseases, and puts forward suggestions for remote consultation and emergency treatment of dentists. From the perspective of social role, dentists not only played the role of expert in dental home professional guidance, but also played the role of psychological counseling for patients.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.29390461379454114\n",
      "PMC_ID:  nan\n",
      "Title:  Psychological intervention in oral patients in novel coronavirus pneumonia outbreak period\n",
      "Abstract:  Public health emergencies have an impact on the public mental health. The outbreak of the novel coronavirus has affected the normal diagnosis and treatment services in oral medical institutions across the country. Delay of non-emergency dental service will have a potential impact on the experience, cognition, treatment and rehabilitation of patients with oral diseases. Through literature review, this paper reviewed the oral psychosomatic diseases closely related to patients' psychological state, such as oral mucosal disease, temporomandibular joint disease, bruxism, periodontal disease and so on. It was believed that these patients might be more susceptible to the impact of stress events, and dental specialists should pay more attention to them. At the same time, this paper analyzes the possible psychological stress symptoms of patients with different oral diseases, and puts forward suggestions for remote consultation and emergency treatment of dentists. From the perspective of social role, dentists not only played the role of expert in dental home professional guidance, but also played the role of psychological counseling for patients.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.25889608367416894\n",
      "PMC_ID:  nan\n",
      "Title:  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\n",
      "Abstract:  In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tract and then induced pneumonia, thus molecular diagnosis based on oral swabs was used for confirmation of this disease. Likewise, patient will be released upon two times of negative detection from oral swabs. However, many coronaviruses can also be transmitted through oral-fecal route by infecting intestines. Whether 2019-nCoV infected patients also carry virus in other organs like intestine need to be tested. We conducted investigation on patients in a local hospital who were infected with this virus. We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral-fecal route. We also showed serology test can improve detection positive rate thus should be used in future epidemiology. Our report provides a cautionary warning that 2019-nCoV may be shed through multiple routes.\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.18786704573057944\n",
      "PMC_ID:  nan\n",
      "Title:  Advices on the prevention and control of nosocomial infection of novel coronavirus within childrens hospitals\n",
      "Abstract:  The pneumonia caused by the novel coronavirus (2019-nCoV), which began in December 2019, has become the most serious public health problem, threatening people's health and life. This threat is posing a severe challenge on the diagnosis and treatment of 2019-nCoV infection, the prevention and control of hospital cross infection of medical staff. It is suggested that in addition to strengthening the organization and leadership of the abovementioned work, establishing and improving the prevention and control mechanism deserve greater attention. Furthermore, special attention should be given to the safety of the medical staff, strengthening their infection monitoring and outbreak management. Medical staff in different work areas and positions should be placed under careful protection, cleaning and disinfection measures. The protection during specimen collection, transportation and medical waste management should also be prioritized. This paper also put forward management suggestions for the outpatient department, isolation ward and other key departments. These measures are proposed to provide a guidance for the prevention and control of 2019-nCoV nosocomial infection in the pediatric outpatient and ward.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.18276486040067907\n",
      "PMC_ID:  nan\n",
      "Title:  The prevention and control of a new coronavirus infection in department of stomatology\n",
      "Abstract:  During a short period of time, the outbreak of pneumonia caused by a novel coronavirus, named Novel Coronavirus Pneumonia (NCP), was first reported in China, spreading to 24 countries and regions rapidly. The number of confirmed cases and deaths continued to rise. World Health Organization (WHO) announced that the outbreaks of the novel coronavirus have constituted a Public Health Emergency of International Concern. Efficient infection control can prevent the virus from further spreading, which makes the epidemic situation under control. Due to the specialty of oral healthcare settings, the risk of cross infection is severe among patients and oral healthcare practitioners. It's more urgent to implement strict and efficient infection control protocols. This paper, based on existing guidelines and published researches pertinent to dental infection-control principles and practices, mainly discusses epidemiological characteristics of NCP and the features of nosocomial infection in oral healthcare settings, and furthermore provides recommendations on patient's evaluation, and infection control protocols in department of stomatology under current circumstance..\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Use of AI in real-time health care delivery to evaluate interventions, risk factors, and outcomes in a way that could not be done manually.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.20397472286477902\n",
      "PMC_ID:  nan\n",
      "Title:  Artificial intelligence finds drugs that could fight the new coronavirus\n",
      "Abstract:  Two independent groups last week reported that they had used artificial intelligence in different ways to find possible treatments for the novel coronavirus, named 2019-nCoV. On Feb. 4, researchers from the AI drug discovery company BenevolentAI and Imperial College London reported that they had used AI software to find an already-approved drug that might limit the viruss ability to infect people (Lancet 2020, DOI: 10.1016/S0140-6736(20)30304-4). On Feb. 6, Insilico Medicine announced that its AI algorithms had designed new molecules that could stop the virus from replicating in peoples bodies. The company says it submitted a paper to the bioRxiv server, but the preprint had not been posted there as of press time. BenevolentAIs algorithms connect molecular structure data to biomedical information about relevant receptors and diseases to find potential drug targets. The group adapted its search to newly available information about 2019-nCoV and focused on the enzyme adaptor-associated protein kinase\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.16326820478986237\n",
      "PMC_ID:  PMC5023790\n",
      "Title:  Risks of Death and Severe Disease in Patients With Middle East Respiratory Syndrome Coronavirus, 20122015\n",
      "Abstract:  Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen, first recognized in 2012, with a high case fatality risk, no vaccine, and no treatment beyond supportive care. We estimated the relative risks of death and severe disease among MERS-CoV patients in the Middle East between 2012 and 2015 for several risk factors, using Poisson regression with robust variance and a bootstrap-based expectation maximization algorithm to handle extensive missing data. Increased age and underlying comorbidity were risk factors for both death and severe disease, while cases arising in Saudi Arabia were more likely to be severe. Cases occurring later in the emergence of MERS-CoV and among health-care workers were less serious. This study represents an attempt to estimate risk factors for an emerging infectious disease using open data and to address some of the uncertainty surrounding MERS-CoV epidemiology.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.15810074388958928\n",
      "PMC_ID:  nan\n",
      "Title:  Guidelines for pregnant women with suspected SARS-CoV-2 infection\n",
      "Abstract:  Coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) can cause severe adverse pregnancy outcomes, such as miscarriage, premature delivery, intrauterine growth restriction, and maternal death.1 , 2 Vertical transmission of the virus responsible for 2019 novel coronavirus disease (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has not yet been detected, whereas perinatal transmission has been suspected in one case.3 Consequences of infection with SARS-CoV-2 for pregnancies are uncertain, with no evidence so far of severe outcomes for mothers and infants; however, the possibility should be considered.4 The recent experience with Zika virus suggests that when a new pathogen emerges, the health-care community should be prepared for the worst-case scenario.5 Therefore, recommendations for management of pregnant women at risk of SARS-CoV-2 infection are urgently needed. To this end, we propose a detailed management algorithm for health-care providers (appendix).\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.14978454211241476\n",
      "PMC_ID:  PMC5454172\n",
      "Title:  MERS-coronavirus: From discovery to intervention\n",
      "Abstract:  Middle East respiratory syndrome coronavirus (MERS-CoV) still causes outbreaks despite public awareness and implementation of health care measures, such as rapid viral diagnosis and patient quarantine. Here we describe the current epidemiological picture of MERS-CoV, focusing on humans and animals affected by this virus and propose specific intervention strategies that would be appropriate to control MERS-CoV. One-third of MERS-CoV patients develop severe lower respiratory tract infection and succumb to a fatal outcome; these patients would require effective therapeutic antiviral therapy. Because of the lack of such intervention strategies, supportive care is the best that can be offered at the moment. Limiting viral spread from symptomatic human cases to health care workers and family members, on the other hand, could be achieved through prophylactic administration of MERS-CoV neutralizing antibodies and vaccines. To ultimately prevent spread of the virus into the human population, however, vaccination of dromedary camels  currently the only confirmed animal host for MERS-CoV  may be the best option to achieve a sustained drop in human MERS cases in time. In the end, a One Health approach combining all these different efforts is needed to tackle this zoonotic outbreak.\n",
      "Has full text:  False\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.14362693421435702\n",
      "PMC_ID:  PMC4622256\n",
      "Title:  Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014\n",
      "Abstract:  Middle East respiratory syndrome coronavirus (MERS-CoV) causes a spectrum of illness. We evaluated whether cycle threshold (C(t)) values (which are inversely related to virus load) were associated with clinical severity in patients from Saudi Arabia whose nasopharyngeal specimens tested positive for this virus by real-time reverse transcription PCR. Among 102 patients, median C(t) of 31.0 for the upstream of the E gene target for 41 (40%) patients who died was significantly lower than the median of 33.0 for 61 survivors (p = 0.0087). In multivariable regression analyses, risk factors for death were age >60 years), underlying illness, and decreasing C(t) for each 1-point decrease in C(t)). Results were similar for a composite severe outcome (death and/or intensive care unit admission). More data are needed to determine whether modulation of virus load by therapeutic agents affects clinical outcomes.\n",
      "Has full text:  True\n",
      "\n",
      "Query:  Best practices and critical challenges and innovative solutions and technologies in hospital flow and organization, workforce protection, workforce allocation, community-based support resources, payment, and supply chain management to enhance capacity, efficiency, and outcomes.\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.12993532039788125\n",
      "PMC_ID:  nan\n",
      "Title:  Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China\n",
      "Abstract:  On December 31, 2019, the Wuhan Municipal Health Commission announced an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), China is now at a critical period in the control of the epidemic. The Chinese Government has been taking a series of rapid, comprehensive, and effective prevention and control measures. As the pandemic has developed, a fact has become apparent: there is a serious dearth of emergency medical supplies, and especially an extreme shortage of personal protective equipment such as masks and medical protective clothing. This is one of the major factors affecting the progress of epidemic prevention and control. Although China has made great efforts to strengthen the ability to quickly respond to public health emergencies since the SARS outbreak in 2003 and it has clarified requirements for emergency supplies through legislation, the emergency reserve supplies program has not been effectively implemented, and there are also deficiencies in the types, quantity, and availability of emergency medical supplies. A sound system of emergency reserve supplies is crucial to the management of public health emergencies. Based on international experiences with pandemic control, the world should emphasize improving the system of emergency reserve medical supplies in the process of establishing and improving public health emergency response systems, and it should promote the establishment of international cooperative programs to jointly deal with public health emergencies of international concern in the future.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.12299922880920189\n",
      "PMC_ID:  nan\n",
      "Title:  Looming threat of COVID-19 infection in Africa: act collectively, and fast\n",
      "Abstract:  Models that enable the continent to better allocate scarce resources to better prepare and respond to the COVID-19 epidemic are crucial. The modelling study by Marius Gilbert and colleagues in The Lancet identifies each African country's risk of importation of COVID-19 from China, using data on the volume of air travel from three airports in provinces in China to African countries. Gilbert and colleagues use two indicators to determine the capacity of countries to detect and respond to cases: preparedness, using the WHO International Health Regulations Monitoring and Evaluation Framework; and vulnerability, using the Infectious Disease Vulnerability Index. Based on their analysis, Egypt, Algeria, and South Africa had the highest importation risk, and a moderate to high capacity to respond to outbreaks. Nigeria, Ethiopia, Sudan, Angola, Tanzania, Ghana, and Kenya had moderate risk with variable capacity and high vulnerability. In the model, the risk mainly originates from Guangdong, Fujian, and Beijing. The study provides a valuable tool that can help countries in Africa prioritise and allocate resources as they prepare to respond to the potential introduction and spread of COVID-19.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.11700109220016286\n",
      "PMC_ID:  nan\n",
      "Title:  Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters\n",
      "Abstract:  Just a few weeks before the first confirmed case of novel coronavirus (COVID-19) was reported in the United States, the US Centers for Disease Control and Prevention (CDC) issued a bold promise to the nation: the agency will use its scientific expertise to bring a new level of preparedness in the United States and global health security against current and growing threats, finally eliminate certain diseases, and bring an end to the devastation of epidemics.(1) The current outbreak of COVID-19 reminds us how urgent this promise is and just how critical it is to continue to sustain and strengthen our nation's public health infrastructure. The unprecedented pace of the public health response to COVID-19 has only been possible because of prior investments in public health preparedness. To accelerate our pace and meet the challenges of current and future health threats, we must advance our world-class data and analytics capabilities; maintain and expand our state-of-the-art public health laboratory capacity; continue building a workforce of trusted, expert, public health professionals; sustain our capacity to rapidly respond to outbreaks at their source; and assure a strong global and domestic preparedness capacity. (Am J Public Health. Published online ahead of print February 13, 2020: e1-e2. doi:10.2105/AJPH.2020.305618).\n",
      "Has full text:  nan\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.10852880686761557\n",
      "PMC_ID:  PMC5719735\n",
      "Title:  Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\n",
      "Abstract:  OBJECTIVE: Recognizing increasing interest in community disease surveillance globally, the goal of this study was to investigate whether respiratory viruses circulating in the community may be represented through clinical (hospital) surveillance in Nigeria. RESULTS: Children were selected via convenience sampling from communities and a tertiary care center (n=91) during spring 2017 in Ilorin, Nigeria. Nasal swabs were collected and tested using polymerase chain reaction. The majority (79.1%) of subjects were under 6years old, of whom 46 were infected (63.9%). A total of 33 of the 91 subjects had one or more respiratory tract virus; there were 10 cases of triple infection and 5 of quadruple. Parainfluenza virus 4, respiratory syncytial virus B and enterovirus were the most common viruses in the clinical sample; present in 93.8% (15/16) of clinical subjects, and 6.7% (5/75) of community subjects (significant difference, p<0.001). Coronavirus OC43 was the most common virus detected in community members (13.3%, 10/75). A different strain, Coronavirus OC 229 E/NL63 was detected among subjects from the clinic (2/16) and not detected in the community. This pilot study provides evidence that data from the community can potentially represent different information than that sourced clinically, suggesting the need for community surveillance to enhance public health efforts and scientific understanding of respiratory infections.\n",
      "Has full text:  True\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.1080595027731317\n",
      "PMC_ID:  nan\n",
      "Title:  Risk Management of COVID-19 by Universities in China\n",
      "Abstract:  The rapid spread of new coronaviruses throughout China and the world in 2019&ndash;2020 has had a great impact on China&rsquo;s economic and social development. As the backbone of Chinese society, Chinese universities have made significant contributions to emergency risk management. Such contributions have been made primarily in the following areas: alumni resource collection, medical rescue and emergency management, mental health maintenance, control of staff mobility, and innovation in online education models. Through the support of these methods, Chinese universities have played a positive role in the prevention and control of the epidemic situation. However, they also face the problems of alumni&rsquo;s economic development difficulties, the risk of deadly infection to medical rescue teams and health workers, infection of teachers and students, and the unsatisfactory application of information technology in resolving the crisis. In response to these risks and emergency problems, we propose some corresponding solutions for public dissemination, including issues related to medical security, emergency research, professional assistance, positive communication, and hierarchical information-based teaching.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Efforts to define the natural history of disease to inform clinical care, public health interventions, infection prevention control, transmission, and clinical trials\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.34940854844265323\n",
      "PMC_ID:  nan\n",
      "Title:  Key points of serious adverse eventand protection of patients in ophthalmic clinical trials during novel coronavirus pneumonia outbreak\n",
      "Abstract:  The prevention and control of novel coronavirus pneumonia is the most priority recently, and various measures during the prevention and control period will have varying degrees of impact on the implement of clinical trials. However, various examinations in ophthalmological clinical trials need close contact between operators and patients, which put us at risk of cross-infection. This paper indicated some suggestions based on the criteria of clinical trials under major public health emergencies, the management of clinical trials during epidemic period including the follow-up of subjects, the treatment of epidemic serious adverse event (SAE) and the management requirements of co-sponsors, as well as the requirements and management principles for environment, subjects, examiners and inspection equipment in the process of ophthalmic clinical trials. It may be helpful to the ophthalmic clinical trial researchers and subjects during the period of novel coronavirus infection.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.2726279965789904\n",
      "PMC_ID:  nan\n",
      "Title:  Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need\n",
      "Abstract:  Clinical trial for COVID-19 was first registered on January 23, 2020. In the last few weeks, an escalating number of clinical trials has been planned and registered with ongoing investigations taking place. From the Chinese Clinical Trial Registry (http://www.chictr.org.cn) and U.S. National Library of Medicine Clinical Trial Registry (https://clinicaltrials. gov), there are 125 clinical trials registered by February 18, 2020, focusing on the treatment of COVID-19. There is an upward trend on the number of registered clinical trials (Figure 1). Among the 125 clinical trials on treatment, 33.3% used anti-viral agents, 14.7% anti-inflammation or immunomodulators, 33.3% herbs or traditional Chinese medicine (TCM), 9.3% cell-based therapy, 2.3% antioxidation and 7.0% other approaches. Pharmaceutical companies, government, institutions, physicians and scientists are the main force behind these researches. 17 years ago (2003), SARS affectedAU - Zhang, Tengyue\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.23564560479441732\n",
      "PMC_ID:  PMC6396572\n",
      "Title:  What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review\n",
      "Abstract:  Background: Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in humans in 2012. A systematic literature review was conducted to synthesize current knowledge and identify critical knowledge gaps. Materials and Methods: We conducted a systematic review on MERS-CoV using PRISMA guidelines. We identified 407 relevant, peer-reviewed publications and selected 208 of these based on their contributions to four key areas: virology; clinical characteristics, outcomes, therapeutic and preventive options; epidemiology and transmission; and animal interface and the search for natural hosts of MERS-CoV. Results: Dipeptidyl peptidase 4 (DPP4/CD26) was identified as the human receptor for MERS-CoV, and a variety of molecular and serological assays developed. Dromedary camels remain the only documented zoonotic source of human infection, but MERS-like CoVs have been detected in bat species globally, as well as in dromedary camels throughout the Middle East and Africa. However, despite evidence of camel-to-human MERS-CoV transmission and cases apparently related to camel contact, the source of many primary cases remains unknown. There have been sustained health care-associated human outbreaks in Saudi Arabia and South Korea, the latter originating from one traveler returning from the Middle East. Transmission mechanisms are poorly understood; for health care, this may include environmental contamination. Various potential therapeutics have been identified, but not yet evaluated in human clinical trials. At least one candidate vaccine has progressed to Phase I trials. Conclusions: There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection. There have been few rigorous studies of baseline prevalence, transmission, and spectrum of disease. Terms such as camel exposure and the epidemiological relationships of cases should be clearly defined and standardized. We strongly recommend a shared and accessible registry or database. Coronaviruses will likely continue to emerge, arguing for a unified One Health approach.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.22913345399850216\n",
      "PMC_ID:  nan\n",
      "Title:  Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed\n",
      "Abstract:  The 2019 novel coronavirus (2019-nCoV) pneumonia, believed to have originated in a wet market in Wuhan, Hubei province, China at the end of 2019, has gained intense attention nationwide and globally. To lower the risk of further disease transmission, the authority in Wuhan suspended public transport indefinitely from Jan 23, 2020; similar measures were adopted soon in many other cities in China. As of Jan 25, 2020, 30 Chinese provinces, municipalities, and autonomous regions covering over 13 billion people have initiated first-level responses to major public health emergencies. A range of measures has been urgently adopted,1,2 such as early identification and isolation of suspected and diagnosed cases, contact tracing and monitoring, collection of clinical data and biological samples from patients, dissemination of regional and national diagnostic criteria and expert treatment consensus, establishment of isolation units and hospitals, and prompt provision of medical supplies and external expert teams to Hubei province. The emergence of the 2019-nCoV pneumonia has parallels with the 2003 outbreak of severe acute respiratory syndrome (SARS), which was caused by another coronavirus that killed 349 of 5327 patients with confirmed infection in China.3 Although the diseases have different clinical presentations, the infectious cause, epidemiological features, fast transmission pattern, and insufficient preparedness of health authorities to address the outbreaks are similar. So far, mental health care for the patients and health professionals directly affected by the 2019-nCoV epidemic has been under-addressed, although the National Health Commission of China released the notification of basic principles for emergency psychological crisis interventions for the 2019-nCoV pneumonia on Jan 26, 2020. This notification contained a reference to mental health problems and interventions that occurred during the 2003 SARS outbreak, and mentioned that mental health care should be provided for patients with 2019-nCoV pneumonitis, close contacts, suspected cases who are isolated at home, patients in fever clinics, families and friends of affected people, health professionals caring for infected patients, and the public who are in need. To date, epidemiological data on the mental health problems and psychiatric morbidity of those suspected or diagnosed with the 2019-nCoV and their treating health professionals have not been available; therefore how best to respond to challenges during the outbreak is unknown. The observations of mental health consequences and measures taken during the 2003 SARS outbreak could help inform health authorities and the public to provide mental health interventions to those who are in need.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.22603580257341893\n",
      "PMC_ID:  PMC5165716\n",
      "Title:  Modernising epidemic science: enabling patient-centred research during epidemics\n",
      "Abstract:  BACKGROUND: Emerging and epidemic infectious disease outbreaks are a significant public health problem and global health security threat. As an outbreak begins, epidemiological investigations and traditional public health responses are generally mounted very quickly. However, patient-centred research is usually not prioritised when planning and enacting the response. Instead, the clinical research response occurs subsequent to and separate from the public health response, and is inadequate for evidence-based decision-making at the bedside or in the offices of public health policymakers. DISCUSSION: The deficiencies of the clinical research response to severe acute respiratory syndrome, pandemic influenza, Middle East respiratory syndrome coronavirus and Ebola virus demonstrate that current research models do not adequately inform and improve the quality of clinical care or public health response. Three suggestions for improvements are made. First, integrate the data and sample collection needs for clinical and public health decision-making within a unified framework, combined with a risk-based, rather than a discipline-based, approach to ethical review and consent. Second, develop clinical study methods and tools that are specifically designed to meet the epidemiological and contextual challenges of emerging and epidemic infectious diseases. Third, invest in investigator-led clinical research networks that are primed and incentivised to respond to outbreak infections, and which can call on the support and resources of a central centre of excellence. CONCLUSIONS: It is crucial that the field of epidemic science matures to place patients at the heart of the response. This can only be achieved when patient-centred research is integrated in the outbreak response from day one and practical steps are taken to reduce the barriers to the generation of reliable and useful evidence.\n",
      "Has full text:  True\n",
      "\n",
      "Query:  Efforts to develop a core clinical outcome set to maximize usability of data across a range of trials\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.21461386860584608\n",
      "PMC_ID:  nan\n",
      "Title:  Key points of serious adverse eventand protection of patients in ophthalmic clinical trials during novel coronavirus pneumonia outbreak\n",
      "Abstract:  The prevention and control of novel coronavirus pneumonia is the most priority recently, and various measures during the prevention and control period will have varying degrees of impact on the implement of clinical trials. However, various examinations in ophthalmological clinical trials need close contact between operators and patients, which put us at risk of cross-infection. This paper indicated some suggestions based on the criteria of clinical trials under major public health emergencies, the management of clinical trials during epidemic period including the follow-up of subjects, the treatment of epidemic serious adverse event (SAE) and the management requirements of co-sponsors, as well as the requirements and management principles for environment, subjects, examiners and inspection equipment in the process of ophthalmic clinical trials. It may be helpful to the ophthalmic clinical trial researchers and subjects during the period of novel coronavirus infection.\n",
      "Has full text:  nan\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.21079219409964844\n",
      "PMC_ID:  nan\n",
      "Title:  Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need\n",
      "Abstract:  Clinical trial for COVID-19 was first registered on January 23, 2020. In the last few weeks, an escalating number of clinical trials has been planned and registered with ongoing investigations taking place. From the Chinese Clinical Trial Registry (http://www.chictr.org.cn) and U.S. National Library of Medicine Clinical Trial Registry (https://clinicaltrials. gov), there are 125 clinical trials registered by February 18, 2020, focusing on the treatment of COVID-19. There is an upward trend on the number of registered clinical trials (Figure 1). Among the 125 clinical trials on treatment, 33.3% used anti-viral agents, 14.7% anti-inflammation or immunomodulators, 33.3% herbs or traditional Chinese medicine (TCM), 9.3% cell-based therapy, 2.3% antioxidation and 7.0% other approaches. Pharmaceutical companies, government, institutions, physicians and scientists are the main force behind these researches. 17 years ago (2003), SARS affectedAU - Zhang, Tengyue\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.17632750263342656\n",
      "PMC_ID:  PMC4918159\n",
      "Title:  Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus\n",
      "Abstract:  Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.1697579202826488\n",
      "PMC_ID:  PMC114037\n",
      "Title:  The Membrane M Protein Carboxy Terminus Binds to Transmissible Gastroenteritis Coronavirus Core and Contributes to Core Stability\n",
      "Abstract:  The architecture of transmissible gastroenteritis coronavirus includes three different structural levels, the envelope, an internal core, and the nucleocapsid that is released when the core is disrupted. Starting from purified virions, core structures have been reproducibly isolated as independent entities. The cores were stabilized at basic pH and by the presence of divalent cations, with Mg(2+) ions more effectively contributing to core stability. Core structures showed high resistance to different concentrations of detergents, reducing agents, and urea and low concentrations of monovalent ions (<200 mM). Cores were composed of the nucleoprotein, RNA, and the C domain of the membrane (M) protein. At high salt concentrations (200 to 300 mM), the M protein was no longer associated with the nucleocapsid, which resulted in destruction of the core structure. A specific ionic interaction between the M protein carboxy terminus and the nucleocapsid was demonstrated using three complementary approaches: (i) a binding assay performed between a collection of M protein amino acid substitution or deletion mutants and purified nucleocapsids that led to the identification of a 16-amino-acid (aa) domain (aa 237 to 252) as being responsible for binding the M protein to the nucleocapsid; (ii) the specific inhibition of this binding by monoclonal antibodies (MAbs) binding to a carboxy-terminal M protein domain close to the indicated peptide but not by MAbs specific for the M protein amino terminus; and (iii) a 26-residue peptide, including the predicted sequence (aa 237 to 252), which specifically inhibited the binding. Direct binding of the M protein to the nucleoprotein was predicted, since degradation of the exposed RNA by RNase treatment did not affect the binding. It is proposed that the M protein is embedded within the virus membrane and that the C region, exposed to the interior face of the virion in a population of these molecules, interacts with the nucleocapsid to which it is anchored, forming the core. Only the C region of the M protein is part of the core.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.14543723444606804\n",
      "PMC_ID:  PMC1277709\n",
      "Title:  Field trial evaluation of a reo-coronavirus calf diarrhea vaccine.\n",
      "Abstract:  Field trials were conducted using an experimental, modified live virus, oral vaccine for prevention of reo- and coronavirus calf diarrhea. Prior to the trials, one or both of the specific causative agents were identified from affected calves in each participating herd. In 21 herds, sequential trials were conducted in which results of uninterrupted vaccination were compared with disease rates during a preceding or subsequent control period. In these herds there was a statistically significant reduction in the morbidity and mortality from disease in 1,598 vaccinates compared with the rates in 829 prevaccination control calves. Morbidity and mortality in 206 post-vaccination control calves rose marginally above the rates in the same vaccinates. In 26 other herds, where double blind trials were conducted, rates of morbidity and mortality from disease were virtually the same for 1,080 vaccinated calves and 355 placebo calves. Vaccinates in the sequential trials had the lowest morbidity and mortality rates of any test group in either field trial format. In a selected dairy herd, both field trial formats were implemented and the results compared. In the double blind trial, vaccinates and placebo calves had comparable rates of morbidity and mortality from disease. When a sequential trial was later implemented, a statistically significant reduction in morbidity and mortality occurred in vaccinates compared with rates in control calves.\n",
      "Has full text:  nan\n",
      "\n",
      "Query:  Efforts to determine adjunctive and supportive interventions that can improve the clinical outcomes of infected patients (e.g. steroids, high flow oxygen)\n",
      "\n",
      "#1 article\n",
      "Cosine similarity:  0.2308890053155399\n",
      "PMC_ID:  PMC3016795\n",
      "Title:  Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates\n",
      "Abstract:  Severe acute respiratory syndrome (SARS) poses a major threat to the health of people worldwide. We performed a retrospective case series analysis to assess clinical outcome and identify pretreatment prognostic correlates of SARS, managed under a standardized treatment protocol. We studied 127 male and 196 female patients with a mean age of 4114 (range 1883). All patients, except two, received ribavirin and steroid combination therapy. In 115 (36%) patients, the course of disease was limited. Pneumonitis progressed rapidly in the remaining patients. Sixty-seven (21%) patients required intensive care, and 42 (13%) required ventilator support. Advanced age, high admission neutrophil count, and high initial lactate dehydrogenase level were independent correlates of an adverse clinical outcome. SARS-associated coronavirus caused severe illnesses in most patients, despite early treatment with ribavirin and steroid. This study has identified three independent pretreatment prognostic correlates.\n",
      "Has full text:  True\n",
      "\n",
      "#2 article\n",
      "Cosine similarity:  0.19037767997157118\n",
      "PMC_ID:  nan\n",
      "Title:  Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore\n",
      "Abstract:  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China.To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management.Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.Confirmed SARS-CoV-2 infection.Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir.Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.\n",
      "Has full text:  nan\n",
      "\n",
      "#3 article\n",
      "Cosine similarity:  0.15896830872851997\n",
      "PMC_ID:  PMC3322746\n",
      "Title:  Severe Acute Respiratory Syndromeassociated Coronavirus in Lung Tissue\n",
      "Abstract:  Efforts to contain severe acute respiratory syndrome (SARS) have been limited by the lack of a standardized, sensitive, and specific test for SARS-associated coronavirus (CoV). We used a standardized reverse transcription-polymerase chain reaction assay to detect SARS-CoV in lung samples obtained from well-characterized patients who died of SARS and from those who died of other reasons. SARS-CoV was detected in all 22 postmortem lung tissues (to 10(9) viral copies/g) from 11 patients with probable SARS but was not detected in any of the 23 lung control samples (sample analysis was blinded). The sensitivity and specificity (95% confidence interval) were 100% (84.6% to 100%) and 100% (85.1% to 100%), respectively. Viral loads were significantly associated with a shorter course of illness but not with the use of ribavirin or steroids. CoV was consistently identified in the lungs of all patients who died of SARS but not in control patients, supporting a primary role for CoV in deaths.\n",
      "Has full text:  True\n",
      "\n",
      "#4 article\n",
      "Cosine similarity:  0.15719547612966267\n",
      "PMC_ID:  nan\n",
      "Title:  Critical care management of adults with community-acquired severe respiratory viral infection\n",
      "Abstract:  With the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 1753% of such patients. In addition, novel pathogens including zoonotic coronaviruses like the agents causing Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019 nCoV) are still being identified. Patients with severe RVIs requiring ICU care present typically with hypoxemic respiratory failure. Oseltamivir is the most widely used neuraminidase inhibitor for treatment of influenza; data suggest that early use is associated with reduced mortality in critically ill patients with influenza. At present, there are no antiviral therapies of proven efficacy for other severe RVIs. Several adjunctive pharmacologic interventions have been studied for their immunomodulatory effects, including macrolides, corticosteroids, cyclooxygenase-2 inhibitors, sirolimus, statins, anti-influenza immune plasma, and vitamin C, but none is recommended at present in severe RVIs. Evidence-based supportive care is the mainstay for management of severe respiratory viral infection. Non-invasive ventilation in patients with severe RVI causing acute hypoxemic respiratory failure and pneumonia is associated with a high likelihood of transition to invasive ventilation. Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI. There is a need for more pragmatic and efficient designs to test different therapeutics both individually and in combination.\n",
      "Has full text:  nan\n",
      "\n",
      "#5 article\n",
      "Cosine similarity:  0.15090377293838686\n",
      "PMC_ID:  PMC1746980\n",
      "Title:  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings\n",
      "Abstract:  Background: The clinical response of patients with severe acute respiratory syndrome (SARS) to a combination of lopinavir/ritonavir and ribavirin was examined after establishing the in vitro antiviral susceptibility of the SARS associated coronavirus to a panel of antiviral agents. Methods: The in vitro susceptibility of the prototype of SARS associated coronavirus to a panel of nucleoside analogues and protease inhibitors currently licensed for clinical use was studied. Forty one patients with SARS followed for 3 weeks were treated with a combination of lopinavir/ritonavir and ribavirin. The clinical progress and virological outcomes were monitored and compared with 111 patients treated with ribavirin only who served as historical controls. Results: In vitro antiviral activity against SARS associated coronavirus was demonstrated for lopinavir and ribavirin at concentrations of 4 g/ml and 50 g/ml, respectively, only at 48 hours. The adverse clinical outcome (ARDS or death) was significantly lower in the treatment group than in the historical controls (2.4% v 28.8%, p<0.001) at day 21 after the onset of symptoms. The adverse outcome remained significantly lower in the treatment group than in the controlsboth those diagnosed early (p<0.001) and those diagnosed later in the course of the epidemic (p = 0.002)but there was no significant difference in adverse outcome rates between the two time periods (p = 0.548). No time related difference in outcome was observed in the control groups. A reduction in steroid usage and nosocomial infections was seen in patients initially treated with lopinavir/ritonavir, and these patients had a decreasing viral load and rising peripheral lymphocyte count. Multivariate analysis showed that age, hepatitis B carrier status, and lack of treatment with this antiviral combination were independent predictors of an adverse outcome. Lopinavir/ritonavir treatment was associated with a better outcome even when adjusted for baseline lactate dehydrogenase level. Conclusions: The apparent favourable clinical response with lopinavir/ritonavir and ribavirin supports further randomised placebo controlled trials in patients with SARS.\n",
      "Has full text:  nan\n",
      "\n"
     ]
    }
   ],
   "source": [
    "nDoc = 5\n",
    "outputPath = \"../../../Downloads/2020-03-13/topArt.txt\" \n",
    "retrieveTopLiter(queries, queryDocDist, outputPath, nDoc)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can see that most retrieved articles are highly correlated with the queries, especially for longer queries that provide a more detailed description of the information need. We also noticed that there are repeats articles in the dataset, probably due to the submission of the same article to multiple pre-print or print platforms."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Level 2: retrieve top related sentences based on cosine similarity between tf-idf vectors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now for each retrieved article, check if a full text is available. When a full text is available, the abstracts and all paragraphs in discussion and conclusion sections (if exists) are used for sentence retrieval. When a full text is not available, only the abstract is used. All these contents are then segmented into sentences and combined for retrieving the top n related sentences for a query. The motivation behind retrieving sentences is that we are expecting the most relevant sentences may help compose a summary paragraph for each query."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {},
   "outputs": [],
   "source": [
    "def findFile(name, path):\n",
    "    \"\"\"\n",
    "    Function to locate a file in a directory.\n",
    "    Input:\n",
    "        name: a string gives the name of the target file.\n",
    "        path: a string gives the directory to search the file.\n",
    "    Output:\n",
    "        return the path of the target file if the file is found. Otherwise return None.\n",
    "    \"\"\"\n",
    "    for root, dirs, files in os.walk(path):\n",
    "        if name in files:\n",
    "            return os.path.join(root, name)\n",
    "    return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "metadata": {},
   "outputs": [],
   "source": [
    "def retrieveTopSent(queries, queryDocDist, dataPath, outputPath, nDoc = 5, nSent = 10, showResults = True):\n",
    "    \"\"\"\n",
    "    Function to retrieve the top n sentences for each query based on cosine similarities between query tf-idf \n",
    "    representations and sentence tf-idf representations.\n",
    "    The retrieval is done by steps:\n",
    "        1. retrive the top nDoc literatures related to each query.\n",
    "        2. from the top nDoc literatures retrieve the top nSent sentences related to each query.\n",
    "    Input:\n",
    "        queries: a list of m strings where each string is a text normalized query.\n",
    "        queryDocDist: a m x n array that gives the pairwise cosine similarity between the m queries and n literatures.\n",
    "        dataPath: a string specifies the path to the full-text files.\n",
    "        outputPath: a string specifies the path to the output file.\n",
    "        nDoc (default 5): the number of literatures to be retrieved for each query.\n",
    "        nSent (default 10): the number of sentences to be retrieved for eacu query.\n",
    "        showResults (default True): whether show the results in the terminal.\n",
    "    \"\"\"\n",
    "    outputFile = open(outputPath, \"w\")\n",
    "    for i in range(len(queries)):\n",
    "        query = queries[i]\n",
    "        print(\"Query: \", query)\n",
    "        print(\"\")\n",
    "        outputFile.write(\"Query: \" + queries[i] + \"\\n\\n\")\n",
    "        querySents = []\n",
    "        sentPmcid = []\n",
    "        for idx in queryDocDist[i].argsort()[-nDoc:][::-1]:\n",
    "            docMeta = metaData[metaData[\"abstract\"].notnull()].iloc[idx]\n",
    "            docRepText = docMeta[\"abstract\"] # Include abstract to represent a literature\n",
    "            pmcid = docMeta[\"pmcid\"]\n",
    "            if docMeta[\"has_full_text\"] == True: # Has full text\n",
    "                sha = docMeta[\"sha\"]\n",
    "                jsonFile = findFile(sha + \".json\", dataPath) # Retrieve the full text with sha\n",
    "                if jsonFile:\n",
    "                    with open(jsonFile) as f:\n",
    "                        doc = json.load(f)\n",
    "                    for para in doc[\"body_text\"]:\n",
    "                        if para[\"section\"].lower() in [\"discussion\", \"conclusion\"]: \n",
    "                            docRepText = docRepText + \" \" + para[\"text\"] # Include paragraphs in discussion and conclusion\n",
    "            docRepSents = sent_tokenize(docRepText) # Sentence segmentation\n",
    "            querySents = querySents + docRepSents # Add sentences of this literature to all sentences related to the query\n",
    "            sentPmcid = sentPmcid + [pmcid] * len(docRepSents)\n",
    "        normQuerySents = [textNormalize(sent) for sent in querySents] # Text normalization for all sentences\n",
    "        qVectorizer = TfidfVectorizer(tokenizer = word_tokenize) # Learn a vectorizer for retrieiving sentences\n",
    "        qVectorizer.fit(normQuerySents)\n",
    "        print(\"Vocabulary size: \", len(qVectorizer.get_feature_names()))\n",
    "        print(\"\")\n",
    "        sentTermMatrix = qVectorizer.transform(normQuerySents).toarray() # Transfer sentences to sentence-term matrix\n",
    "        queryTermMatrix = qVectorizer.transform([textNormalize(query)]).toarray() # Transfer the query to query-term matrix\n",
    "        querySentDist = 1 - cdist(queryTermMatrix, sentTermMatrix, metric = 'cosine') # Compute cosine similarity\n",
    "        sentCount = 1\n",
    "        for iidx in querySentDist[0].argsort()[-nSent:][::-1]: # Show the top n related sentences\n",
    "            if np.isnan(querySentDist[0][iidx]):\n",
    "                continue\n",
    "            if showResults:\n",
    "                print(\"#\" + str(sentCount) + \" sentence\")\n",
    "                print(\"Cosine similarity: \", querySentDist[0][iidx])\n",
    "                print(\"PMC_ID: \", sentPmcid[iidx])\n",
    "                print(querySents[iidx])\n",
    "                print(\"\")\n",
    "            outputFile.write(\"#\" + str(sentCount) + \" sentence\\n\")\n",
    "            outputFile.write(\"Cosine similarity: \" + str(round(querySentDist[0][iidx], 5)) + \"\\n\")\n",
    "            outputFile.write(\"PMC_ID: \" + str(sentPmcid[iidx]) + \"\\n\")\n",
    "            outputFile.write(querySents[iidx] + \"\\n\\n\")\n",
    "            sentCount += 1\n",
    "    outputFile.close()\n",
    "    return"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Query:  Resources to support skilled nursing facilities and long term care facilities.\n",
      "\n",
      "Vocabulary size:  204\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.4277623335395082\n",
      "PMC_ID:  PMC6154147\n",
      "We describe an outbreak of severe respiratory illness associated with human coronavirus NL63 in a long-term care facility in Louisiana in November 2017.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.21762101621888608\n",
      "PMC_ID:  nan\n",
      "While ensuring the completion of treatment work, we manage to leverage nursing human resources in a scientific, standardized and maximized efficiency manner, to ensure the quality of nursing, and the physical and mental health of nursing staff.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.21393483063924768\n",
      "PMC_ID:  PMC4630490\n",
      "Ninety-seven percent (181/186) of the cases had exposure to the health care facilities.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.17134737594010996\n",
      "PMC_ID:  nan\n",
      "The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1659876294580771\n",
      "PMC_ID:  PMC2870246\n",
      "These outbreaks establish this virus as a cause of morbidity in aged-care facilities and add to increasing evidence of the significance of coronavirus infections.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.13749358346438667\n",
      "PMC_ID:  PMC2870246\n",
      "Three outbreaks of respiratory illness associated with human coronavirus HCoV-OC43 infection occurred in geographically unrelated aged-care facilities in Melbourne, Australia during August and September 2002.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.12036762061246653\n",
      "PMC_ID:  PMC2870246\n",
      "Attack rates and symptoms were similar in residents and staff across the facilities.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.09003041720301652\n",
      "PMC_ID:  PMC4630490\n",
      "As in severe acute respiratory syndrome outbreaks, superspreading events can cause a large outbreak of MERS in healthcare facilities with severe consequences.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.0814788259625675\n",
      "PMC_ID:  PMC4630490\n",
      "All healthcare facilities should establish and implement infection prevention and control measure as well as triage policies and procedures for early detection and isolation of suspected MERS-CoV cases.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.08124378580385794\n",
      "PMC_ID:  nan\n",
      "Nurses will be required to react to these events, even though they will also be affected as ordinary citizens.\n",
      "\n",
      "Query:  Mobilization of surge medical staff to address shortages in overwhelmed communities\n",
      "\n",
      "Vocabulary size:  498\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.24186996022126384\n",
      "PMC_ID:  nan\n",
      "Medical institutions should strengthen the training of psychological skills of medical staff.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.19770823375626967\n",
      "PMC_ID:  PMC4405869\n",
      "After the sessions, faculty, students and staff were asked about what was learned through the sessions, and what educational needs still needed to be addressed.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.19600883849612116\n",
      "PMC_ID:  nan\n",
      "As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.19600883849612116\n",
      "PMC_ID:  nan\n",
      "As outbreaks surge worldwide, scientists fear that COVID-19 might soon become pandemic.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.17749579639184698\n",
      "PMC_ID:  nan\n",
      "Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91  10.89).\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.17449497100737932\n",
      "PMC_ID:  PMC4405869\n",
      "While most gaps in knowledge were addressed after an intense information seminar, other learning needs were identified and responded to.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.1602470972284219\n",
      "PMC_ID:  PMC4405869\n",
      "Data was gathered on gaps in participant knowledge and a plan was developed to address the gaps.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.15737875214125785\n",
      "PMC_ID:  nan\n",
      "The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92  17.88).\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.15341281083108138\n",
      "PMC_ID:  nan\n",
      "The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.7811.12) vs (39.14  9.01), t =-2.548, P=0.012].\n",
      "\n",
      "Query:  Age-adjusted mortality data for Acute Respiratory Distress Syndrome (ARDS) with/without other organ failure  particularly for viral etiologies\n",
      "\n",
      "Vocabulary size:  475\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.3608942602004993\n",
      "PMC_ID:  PMC527336\n",
      "The following baseline factors were independently associated with worse survival: older age (6180 years) (adjusted hazard ratio [HR] 5.24, 95% confidence interval [CI] 2.0313.53), presence of an active comorbid condition (adjusted HR 3.36, 95% CI 1.447.82) and higher initial viral load of SARS coronavirus, according to quantitative PCR of nasopharyngeal specimens (adjusted HR 1.21 per log(10) increase in number of RNA copies per millilitre, 95% CI 1.061.39).\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.35778417411193164\n",
      "PMC_ID:  PMC5578707\n",
      "Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel virus that emerged in 2012, causing acute respiratory distress syndrome (ARDS), severe pneumonia-like symptoms, and multi-organ failure, with a case fatality rate of ~36%.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.2925342587829156\n",
      "PMC_ID:  PMC6805532\n",
      "Patients who were admitted with septic shock and/or organ failure were significantly more likely to die than patients who were admitted with pneumonia and/or acute respiratory distress syndrome (OR=47.9, 95% CI=3.9, 585.5, p-value 0.002).\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.27127187304949696\n",
      "PMC_ID:  PMC527336\n",
      "Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.26284708777755994\n",
      "PMC_ID:  PMC6805532\n",
      "Pneumonia and acute respiratory distress syndrome were the most common associated conditions that MERS-CoV patients had when they were admitted to the hospital.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.2516086891881836\n",
      "PMC_ID:  PMC2704758\n",
      "Advanced age was significantly associated with increased SARS-related deaths, primarily due to the onset of early- and late-stage acute respiratory distress syndrome (ARDS) and pulmonary fibrosis.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.2471979006565903\n",
      "PMC_ID:  PMC4267971\n",
      "Respiratory viruses can cause a wide spectrum of pulmonary diseases, ranging from mild, upper respiratory tract infections to severe and life-threatening lower respiratory tract infections, including the development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.23642394807396439\n",
      "PMC_ID:  PMC4267971\n",
      "Severe acute respiratory syndrome (SARS) coronavirus and Middle East respiratory syndrome (MERS) coronavirus cause severe infection of the lower respiratory tract, with 10% and 35% overall mortality rates, respectively; however, >50% mortality rates are seen in the aged and immunosuppressed populations.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.22678917513638253\n",
      "PMC_ID:  PMC527336\n",
      "RESULTS: Thirty-two patients (24.1%) met the criteria for acute respiratory distress syndrome, and 24 patients (18.0%) died.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.22556113988746596\n",
      "PMC_ID:  PMC6805532\n",
      "Presenting with septic shock and organ failure at admission was significantly associated with hospital mortality.\n",
      "\n",
      "Query:  Extracorporeal membrane oxygenation (ECMO) outcomes data of COVID-19 patients\n",
      "\n",
      "Vocabulary size:  539\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.4362109518466799\n",
      "PMC_ID:  PMC5768582\n",
      "The objective of this study is to compare the outcomes of MERS-CoV patients before and after the availability of extracorporeal membrane oxygenation (ECMO) as a rescue therapy in severely hypoxemic patients who failed conventional strategies.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.3903124386797483\n",
      "PMC_ID:  PMC4945721\n",
      "Mechanical ventilation, extracorporeal membrane oxygenation, and convalescent serum were employed for 24.5%, 7.1%, and 3.8% of patients, respectively.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.31126025763969256\n",
      "PMC_ID:  nan\n",
      "Along with the sharp increase of confirmed cases novel coronavirus infection, more critically ill cases require extracorporeal membrane oxygenation (ECMO) support.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.28008730332580356\n",
      "PMC_ID:  nan\n",
      "They found 18 COVID-19 patients with cancer histories among 1590 COVID-19 patients from 575 hospitals in 31 provincial regions.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.2503647694876934\n",
      "PMC_ID:  nan\n",
      "COVID-19 is a highly contagious infection to which everyone, to our knowledge, is susceptible; the most important morbidity factor is exposure to an infection source.2 Furthermore, although the authors indicate that patients with cancer had worse outcomes from COVID-19, they also reported the median age of these patients (631 years) to be significantly higher than for those without cancer (487 years), suggesting that older age is associated with worse COVID-19 outcomes\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.21889408128645482\n",
      "PMC_ID:  nan\n",
      "Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.20205003529023458\n",
      "PMC_ID:  nan\n",
      "The authors concluded by use of epidemiological statistics that because the proportion of patients with cancer histories was higher in a cohort with COVID-19 than in the population in China, patients with cancer were more likely to develop COVID-19.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.18411835866025794\n",
      "PMC_ID:  nan\n",
      "Based on the clinical data of novel coronavirus pneumonia (NCP), as well as the dada from previous clinical studies and the recommendations from the Extracorporeal Life Support Organization (ELSO), the committee board of the Chinese Society of Extracorporeal Life Support (CSECLS) made this recommendations to guide clinical ECMO application in the patients with NCP.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.17992470851830067\n",
      "PMC_ID:  PMC5768582\n",
      "Our primary outcome was in-hospital mortality; secondary outcomes included ICU and hospital length of stay.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.17155223878890202\n",
      "PMC_ID:  PMC4945721\n",
      "Second, we have presented 4 months of clinical data after control of the outbreak, and thus the data might represent acute complications of MERS-CoV-infected patients.\n",
      "\n",
      "Query:  Outcomes data for COVID-19 after mechanical ventilation adjusted for age.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vocabulary size:  650\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.3501958230554416\n",
      "PMC_ID:  nan\n",
      "Many severe hypoxemic patients only receive high-flow nasal oxygen (HFNO) or noninvasive mechanical ventilation rather than invasive mechanical ventilation because of intubation delay or lack of mechanical ventilators (especially at early phase).\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.31533090925940754\n",
      "PMC_ID:  nan\n",
      "Our preliminary data show that only about 25% of patients who died were intubated and received mechanical ventilation.JO - Intensive Care Medicine\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.24743381145789278\n",
      "PMC_ID:  nan\n",
      "29 (56%) of 52 patients were given non-invasive ventilation at ICU admission, of whom 22 (76%) required further orotracheal intubation and invasive mechanical ventilation.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.20121731154011047\n",
      "PMC_ID:  PMC3999990\n",
      "Likewise, advanced age correlated with more adverse disease outcomes following severe acute respiratory syndrome coronavirus (SARS-CoV) infection in humans.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1802343790285732\n",
      "PMC_ID:  nan\n",
      "The ICU mortality rate among those who required non-invasive ventilation was 23 (79%) of 29 and among those who required invasive mechanical ventilation was 19 (86%) of 22.2 Jonathan Chun-Hei Cheung and colleagues3 do not recommend use of a high-flow nasal cannula or non-invasive ventilation until the patient has viral clearance.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.1695216999769834\n",
      "PMC_ID:  PMC3999990\n",
      "Taken together, our data indicate that systemic and mucosal immunity to SARS-CoV infection differs in the aged as compared to the juvenile host.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.16211703879455208\n",
      "PMC_ID:  nan\n",
      "COVID-19 causes COVID-19 disease that has similar symptoms as SARS-CoV.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.15079307354027893\n",
      "PMC_ID:  PMC3999990\n",
      "Our data is not consistent with the exacerbated acute inflammatory responses shown to promote disease pathogenesis in aged SARS-CoV-infected mouse models [19, 21] .\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.14640317966094363\n",
      "PMC_ID:  PMC3999990\n",
      "We used an aged African green monkey SARS-CoV infection model to better understand age-related mechanisms of increased susceptibility to viral respiratory infections.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.12632634720007108\n",
      "PMC_ID:  nan\n",
      "Lack of critical care resource in face of COVID-19 epidemics Based on data reported by the National Health Commission of China, there have been about 2000 new confirmed cases and?>?4000 suspected cases daily over the past week in Wuhan [3].\n",
      "\n",
      "Query:  Knowledge of the frequency, manifestations, and course of extrapulmonary manifestations of COVID-19, including, but not limited to, possible cardiomyopathy and cardiac arrest.\n",
      "\n",
      "Vocabulary size:  389\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.20401520191732225\n",
      "PMC_ID:  nan\n",
      "In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.16720269757804485\n",
      "PMC_ID:  nan\n",
      "It has certain characteristics and changes rapidly with the course of the disease.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.16666791260400837\n",
      "PMC_ID:  nan\n",
      "In the acute phase, GGO and crazy paving are the main manifestations.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.159531985205988\n",
      "PMC_ID:  nan\n",
      "In the acute stage, GGO and paving stone sign were the main manifestations.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1366822876088153\n",
      "PMC_ID:  PMC484515\n",
      "However, the high background prevalence of these responses limits their diagnostic value.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.13658841963467638\n",
      "PMC_ID:  PMC484515\n",
      "OBJECTIVE: To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.12920063037092344\n",
      "PMC_ID:  nan\n",
      "Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is a betacoronavirus that affects the lower respiratory tract and manifests as pneumonia in humans.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.1191710559101743\n",
      "PMC_ID:  PMC484515\n",
      "DESIGN: Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.1144796839763299\n",
      "PMC_ID:  nan\n",
      "Methods CT manifestations of two confirmed cases of NCP were reported, meanwhile the literatures on SARS and MERS imaging performance were reviewed and summarized.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.0903864044031597\n",
      "PMC_ID:  PMC1888177\n",
      "We have summarized and illustrated the gross, microscopic, and ultrastructural alterations for these myocardial diseases; and, whenever possible, we have reviewed their biochemical pathogenesis.\n",
      "\n",
      "Query:  Application of regulatory standards (e.g., EUA, CLIA) and ability to adapt care to crisis standards of care level.\n",
      "\n",
      "Vocabulary size:  409\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.2913868177359993\n",
      "PMC_ID:  PMC4932258\n",
      "Participants will be randomised to either preoperative patient education comprising of a video and ICU tour with standard care (intervention) or standard education (control).\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.21338519974134706\n",
      "PMC_ID:  PMC4932258\n",
      "Providing information about postoperative care in the intensive care unit (ICU) to patients and families may lead to lower anxiety levels, and increased satisfaction with healthcare.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.20124991305133588\n",
      "PMC_ID:  nan\n",
      "Second, we specified the protection levels for different types of health care activities.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.19908328100736472\n",
      "PMC_ID:  nan\n",
      "If we assume that average levels of health care are similar throughout China, higher numbers of infections in a given population can be considered an indirect indicator of a heavier health-care burden.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1734891170213152\n",
      "PMC_ID:  PMC6695009\n",
      "Full precautions should be applied and carefully followed to prevent the transmission of the virus, especially among health care workers.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.16084600007502625\n",
      "PMC_ID:  PMC4932258\n",
      "The primary outcome measures are the satisfaction levels of patients and family members with ICU care and decision-making in the ICU.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.14722493688475058\n",
      "PMC_ID:  PMC3322746\n",
      "With the use of standardized commercially available assays, comparison of results from different centers may be facilitated. \n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.1379029116341266\n",
      "PMC_ID:  PMC3322746\n",
      "By using a standardized RT-PCR assay, SARS-CoV has been unequivocally identified in the lung tissue of all patients who died with probable SARS but not in any of the controls.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.13528908061542533\n",
      "PMC_ID:  PMC3322746\n",
      "Global efforts to contain SARS have been severely impeded by the lack of a standardized, sensitive, and specific diagnostic test for SARS-CoV.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.125937332821638\n",
      "PMC_ID:  PMC3322746\n",
      "Efforts to contain severe acute respiratory syndrome (SARS) have been limited by the lack of a standardized, sensitive, and specific test for SARS-associated coronavirus (CoV).\n",
      "\n",
      "Query:  Approaches for encouraging and facilitating the production of elastomeric respirators, which can save thousands of N95 masks.\n",
      "\n",
      "Vocabulary size:  272\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.5758519786983136\n",
      "PMC_ID:  PMC6490128\n",
      "Prosectors are advised to routinely wear N-95 respirator masks or powered respirator hoods.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.27097095724021736\n",
      "PMC_ID:  nan\n",
      "Updates on the respiratory illness that has infected tens of thousands of people and killed thousands.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.25746217148776906\n",
      "PMC_ID:  nan\n",
      "As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.1739394184865578\n",
      "PMC_ID:  nan\n",
      "Updates on the respiratory illness that has infected tens of thousands of people.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.15724154497687848\n",
      "PMC_ID:  PMC6490128\n",
      "All published cases of secondary meningococcal disease transmission to healthcare workers invariably arose in scenarios in which face masks/respirators were not employed; none of these cases involved meningococcal disease transmission to ME/C or other morgue staff.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.14140288496731057\n",
      "PMC_ID:  nan\n",
      "Scientists are concerned about a new virus that has infected tens of thousands of people and killed more than 2,000.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.1168874331325358\n",
      "PMC_ID:  nan\n",
      "If everyone puts on a mask in public places, it would help to remove stigmatisation that has hitherto discouraged masking of symptomatic patients in many places.3 Furthermore, transmission from asymptomatic infected individuals has been documented for COVID-19, and viral load is particularly high at early disease stage.4 , 5 Masking, as a public health intervention, would probably intercept the transmission link and prevent these apparently healthy infectious sources.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.09182618411038401\n",
      "PMC_ID:  nan\n",
      "It has long been recommended that for respiratory infections like influenza, affected patients should wear masks to limit droplet spread.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.07267374963711404\n",
      "PMC_ID:  PMC6490128\n",
      "While a surgical mask would normally provide adequate protection from large droplet spread, it does not prevent inhalation of smaller aerosolized particles such as those generated at autopsy.\n",
      "\n",
      "Query:  Best telemedicine practices, barriers and faciitators, and specific actions to remove/expand them within and across state boundaries.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vocabulary size:  457\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.2256151749143892\n",
      "PMC_ID:  nan\n",
      "As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.22485013118264485\n",
      "PMC_ID:  nan\n",
      "Fourteen cases have been diagnosed in the United States, in addition to 39 cases among repatriated persons from high-risk settings, for a current total of 53 cases within the United States.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.2197918278700789\n",
      "PMC_ID:  nan\n",
      "Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.1968208211874105\n",
      "PMC_ID:  nan\n",
      "As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.18612174586246621\n",
      "PMC_ID:  nan\n",
      "We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.18612174586246621\n",
      "PMC_ID:  nan\n",
      "We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.14789903433409368\n",
      "PMC_ID:  nan\n",
      "Interestingly, within the backbone of SARS-CoV spike, cell entry of 2019-nCoV was similar to the other clade 1 spikes tested, including SARS-CoV.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.1374299668428831\n",
      "PMC_ID:  nan\n",
      "As of February 4, 11 cases had been reported in the United States.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.13438888013208605\n",
      "PMC_ID:  nan\n",
      "CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5).\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.12968736641384848\n",
      "PMC_ID:  nan\n",
      "These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States.\n",
      "\n",
      "Query:  Guidance on the simple things people can do at home to take care of sick people and manage disease.\n",
      "\n",
      "Vocabulary size:  229\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.23019741285744844\n",
      "PMC_ID:  nan\n",
      "But public health experts say China is right to prioritize tracking sick patients who are spreading the disease.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.20818776329871724\n",
      "PMC_ID:  nan\n",
      "Executive agencies Public Health England (PHE)1 and Health Protection Scotland (HPS) have since published guidance to healthcare providers on managing patients suspected to have the disease.Guidance for the public and health professionals varies internationally, depending partly on risk levels and healthcare systems, and is being regularly updated.This article offers a practical guide for GPs and others working in UK primary care on when to suspect covid-19 and how to respond.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.17700586248120698\n",
      "PMC_ID:  nan\n",
      "Wales has managed to test 90% of people suspected of being infected with novel coronavirus in their own homes, after implementing community testing for covid-19.Vaughan Gething, minister for health and social services in Wales, credited the NHS with making the process as convenient as possible for people whilst also protecting our ambulance and hospital resources for those who need it most.More than 100 people had been tested in Wales as of 13 February, with no positive cases.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.12582467969120192\n",
      "PMC_ID:  nan\n",
      "The novel coronavirus (2019-nCoV or SARS-CoV-2) is a highly contagious and deadly virus that has infected more than 50 000 people and killed more than 1 000 people in 25 countries around the world.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.11101592694926277\n",
      "PMC_ID:  nan\n",
      "We recommend readers consult the latest guidance (box 1).Box 1 Essential resourcescovid-19: latest case definition, investigation, and initial clinical management of possible cases:https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infectionCoronavirus: latest information and advice including updated list of high risk countries:https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-publicGuidance on isolation of healthcare workers:https://www.gov.uk/government/publications/novel-coronavirus-2019-ncov-guidance-for-healthcare-providers-with-staff-who-have-travelled-to-china/guidance-for-healthcare-providers-healthcare-workers-who-have-travelled-to-chinaFind your local Health Protection Team in England:https://www.gov.uk/health-protection-teamcovid-19: interim guidance  RETURN TO TEXT\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.10681943075051015\n",
      "PMC_ID:  nan\n",
      "Updates on the respiratory illness that has infected tens of thousands of people.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.10681943075051015\n",
      "PMC_ID:  nan\n",
      "Updates on the respiratory illness that has infected tens of thousands of people.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.10473598844077692\n",
      "PMC_ID:  nan\n",
      "It is based on current UK guidance at the time of publication.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.09261264504762068\n",
      "PMC_ID:  nan\n",
      "That outbreak, which also originated in China, killed 774 people worldwide.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.09134045237303523\n",
      "PMC_ID:  nan\n",
      "What you need to knowConsider covid-19 infection in anyone with cough, fever, or breathlessness who has had contact with someone with covid-19, or has returned from a high risk area in the 14 days before the onset of symptomsEvery effort should be made to avoid in-person assessment of patients with possible covid-19 in primary careGP surgeries should plan ahead and develop clear protocols for managing possible cases, including isolation procedures, personal protective equipment, seeking specialist advice, and decontaminationIf covid-19 infection is suspected in someone attending the practice, isolate the patient in a room (away from other patients and staff), close the door, and ask the patient to call NHS 111The guidance may change so it is essential to look at the latest guidance online (box 1)The UK recorded its first confirmed case of acute respiratory infection due to coronavirus disease 2019 (covid-19) on 31 January 2020 and responded by quarantining at-risk individuals to contain the spread of infection.\n",
      "\n",
      "Query:  Oral medications that might potentially work.\n",
      "\n",
      "Vocabulary size:  231\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.22864466389032245\n",
      "PMC_ID:  nan\n",
      "Medical staff in different work areas and positions should be placed under careful protection, cleaning and disinfection measures.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.2088008329568316\n",
      "PMC_ID:  nan\n",
      "Delay of non-emergency dental service will have a potential impact on the experience, cognition, treatment and rehabilitation of patients with oral diseases.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.2088008329568316\n",
      "PMC_ID:  nan\n",
      "Delay of non-emergency dental service will have a potential impact on the experience, cognition, treatment and rehabilitation of patients with oral diseases.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.1720627653248028\n",
      "PMC_ID:  nan\n",
      "It was believed that these patients might be more susceptible to the impact of stress events, and dental specialists should pay more attention to them.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1720627653248028\n",
      "PMC_ID:  nan\n",
      "It was believed that these patients might be more susceptible to the impact of stress events, and dental specialists should pay more attention to them.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.1459494694807253\n",
      "PMC_ID:  nan\n",
      "The outbreak of the novel coronavirus has affected the normal diagnosis and treatment services in oral medical institutions across the country.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.1459494694807253\n",
      "PMC_ID:  nan\n",
      "The outbreak of the novel coronavirus has affected the normal diagnosis and treatment services in oral medical institutions across the country.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.13007025626132673\n",
      "PMC_ID:  nan\n",
      "It is suggested that in addition to strengthening the organization and leadership of the abovementioned work, establishing and improving the prevention and control mechanism deserve greater attention.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.09748816119411885\n",
      "PMC_ID:  nan\n",
      "The protection during specimen collection, transportation and medical waste management should also be prioritized.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.08925001513778463\n",
      "PMC_ID:  nan\n",
      "Furthermore, special attention should be given to the safety of the medical staff, strengthening their infection monitoring and outbreak management.\n",
      "\n",
      "Query:  Use of AI in real-time health care delivery to evaluate interventions, risk factors, and outcomes in a way that could not be done manually.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vocabulary size:  483\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.17093310684088014\n",
      "PMC_ID:  PMC4622256\n",
      "We evaluated whether cycle threshold (C(t)) values (which are inversely related to virus load) were associated with clinical severity in patients from Saudi Arabia whose nasopharyngeal specimens tested positive for this virus by real-time reverse transcription PCR.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.1640021311986225\n",
      "PMC_ID:  PMC5454172\n",
      "Because of the lack of such intervention strategies, supportive care is the best that can be offered at the moment.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.16147992192949223\n",
      "PMC_ID:  PMC4622256\n",
      "We showed that several other risk factors were associated with death and severe outcome on multivariable analysis.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.1607042741491207\n",
      "PMC_ID:  PMC4622256\n",
      "At this time, MERS-CoV has no known treatment, other than supportive care.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.15484145443564223\n",
      "PMC_ID:  PMC4622256\n",
      "Our findings did not change when we adjusted for other risk factors for severe outcome and potential confounders.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.15381770147630702\n",
      "PMC_ID:  nan\n",
      "On Feb. 4, researchers from the AI drug discovery company BenevolentAI and Imperial College London reported that they had used AI software to find an already-approved drug that might limit the viruss ability to infect people (Lancet 2020, DOI: 10.1016/S0140-6736(20)30304-4).\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.1394571649559151\n",
      "PMC_ID:  nan\n",
      "Two independent groups last week reported that they had used artificial intelligence in different ways to find possible treatments for the novel coronavirus, named 2019-nCoV.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.1379122690008463\n",
      "PMC_ID:  PMC4622256\n",
      "If real-time RT-PCR is 100% efficient, a 1-unit change in C t indicates an 2-fold difference in concentration of virus copies, although such conditions are rarely met in real-world practice (12) .\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.13546612612385323\n",
      "PMC_ID:  PMC4622256\n",
      "The strongest risk factors were being elderly and having an underlying illness.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.12910440406671508\n",
      "PMC_ID:  PMC5023790\n",
      "We estimated the relative risks of death and severe disease among MERS-CoV patients in the Middle East between 2012 and 2015 for several risk factors, using Poisson regression with robust variance and a bootstrap-based expectation maximization algorithm to handle extensive missing data.\n",
      "\n",
      "Query:  Best practices and critical challenges and innovative solutions and technologies in hospital flow and organization, workforce protection, workforce allocation, community-based support resources, payment, and supply chain management to enhance capacity, efficiency, and outcomes.\n",
      "\n",
      "Vocabulary size:  414\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.17739007757568903\n",
      "PMC_ID:  nan\n",
      "To accelerate our pace and meet the challenges of current and future health threats, we must advance our world-class data and analytics capabilities; maintain and expand our state-of-the-art public health laboratory capacity; continue building a workforce of trusted, expert, public health professionals; sustain our capacity to rapidly respond to outbreaks at their source; and assure a strong global and domestic preparedness capacity.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.13357600369159184\n",
      "PMC_ID:  nan\n",
      "As the pandemic has developed, a fact has become apparent: there is a serious dearth of emergency medical supplies, and especially an extreme shortage of personal protective equipment such as masks and medical protective clothing.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.13063330587840782\n",
      "PMC_ID:  nan\n",
      "Such contributions have been made primarily in the following areas: alumni resource collection, medical rescue and emergency management, mental health maintenance, control of staff mobility, and innovation in online education models.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.11434893704289661\n",
      "PMC_ID:  nan\n",
      "A sound system of emergency reserve supplies is crucial to the management of public health emergencies.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.09506192690260606\n",
      "PMC_ID:  nan\n",
      "Models that enable the continent to better allocate scarce resources to better prepare and respond to the COVID-19 epidemic are crucial.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.0944522525375594\n",
      "PMC_ID:  nan\n",
      "The study provides a valuable tool that can help countries in Africa prioritise and allocate resources as they prepare to respond to the potential introduction and spread of COVID-19.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.09419136610556555\n",
      "PMC_ID:  PMC5719735\n",
      "There is no report, to the best of our knowledge, implicating coronavirus in ARIs in Nigeria, and it was detected in 12 subjects in this study.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.09271928280664499\n",
      "PMC_ID:  nan\n",
      "Based on their analysis, Egypt, Algeria, and South Africa had the highest importation risk, and a moderate to high capacity to respond to outbreaks.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.08758554749080516\n",
      "PMC_ID:  nan\n",
      "In response to these risks and emergency problems, we propose some corresponding solutions for public dissemination, including issues related to medical security, emergency research, professional assistance, positive communication, and hierarchical information-based teaching.\n",
      "\n",
      "Query:  Efforts to define the natural history of disease to inform clinical care, public health interventions, infection prevention control, transmission, and clinical trials\n",
      "\n",
      "Vocabulary size:  425\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.3291602824916533\n",
      "PMC_ID:  nan\n",
      "The prevention and control of novel coronavirus pneumonia is the most priority recently, and various measures during the prevention and control period will have varying degrees of impact on the implement of clinical trials.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.21849341031355052\n",
      "PMC_ID:  nan\n",
      "The observations of mental health consequences and measures taken during the 2003 SARS outbreak could help inform health authorities and the public to provide mental health interventions to those who are in need.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.21471345714957368\n",
      "PMC_ID:  PMC6396572\n",
      "Conclusions: There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.21319950461044568\n",
      "PMC_ID:  nan\n",
      "This notification contained a reference to mental health problems and interventions that occurred during the 2003 SARS outbreak, and mentioned that mental health care should be provided for patients with 2019-nCoV pneumonitis, close contacts, suspected cases who are isolated at home, patients in fever clinics, families and friends of affected people, health professionals caring for infected patients, and the public who are in need.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.19506356690084914\n",
      "PMC_ID:  PMC6396572\n",
      "We identified 407 relevant, peer-reviewed publications and selected 208 of these based on their contributions to four key areas: virology; clinical characteristics, outcomes, therapeutic and preventive options; epidemiology and transmission; and animal interface and the search for natural hosts of MERS-CoV.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.1686049974444661\n",
      "PMC_ID:  PMC5165716\n",
      "DISCUSSION: The deficiencies of the clinical research response to severe acute respiratory syndrome, pandemic influenza, Middle East respiratory syndrome coronavirus and Ebola virus demonstrate that current research models do not adequately inform and improve the quality of clinical care or public health response.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.1497626127853947\n",
      "PMC_ID:  PMC5165716\n",
      "BACKGROUND: Emerging and epidemic infectious disease outbreaks are a significant public health problem and global health security threat.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.14783896302391364\n",
      "PMC_ID:  PMC6396572\n",
      "Transmission mechanisms are poorly understood; for health care, this may include environmental contamination.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.1436565974403904\n",
      "PMC_ID:  nan\n",
      "From the Chinese Clinical Trial Registry (http://www.chictr.org.cn) and U.S. National Library of Medicine Clinical Trial Registry (https://clinicaltrials.\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.14313006467174494\n",
      "PMC_ID:  nan\n",
      "It may be helpful to the ophthalmic clinical trial researchers and subjects during the period of novel coronavirus infection.\n",
      "\n",
      "Query:  Efforts to develop a core clinical outcome set to maximize usability of data across a range of trials\n",
      "\n",
      "Vocabulary size:  304\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.23406232069694233\n",
      "PMC_ID:  PMC4918159\n",
      "Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.1781939781237064\n",
      "PMC_ID:  PMC4918159\n",
      "Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.16843149013729308\n",
      "PMC_ID:  PMC4918159\n",
      "Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.15495952261227453\n",
      "PMC_ID:  nan\n",
      "From the Chinese Clinical Trial Registry (http://www.chictr.org.cn) and U.S. National Library of Medicine Clinical Trial Registry (https://clinicaltrials.\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1287847789577209\n",
      "PMC_ID:  PMC114037\n",
      "Only the C region of the M protein is part of the core.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.128190829119743\n",
      "PMC_ID:  PMC114037\n",
      "The architecture of transmissible gastroenteritis coronavirus includes three different structural levels, the envelope, an internal core, and the nucleocapsid that is released when the core is disrupted.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.12716551347386884\n",
      "PMC_ID:  nan\n",
      "Clinical trial for COVID-19 was first registered on January 23, 2020.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.12395745938697655\n",
      "PMC_ID:  PMC114037\n",
      "The cores were stabilized at basic pH and by the presence of divalent cations, with Mg(2+) ions more effectively contributing to core stability.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.11309598977034163\n",
      "PMC_ID:  nan\n",
      "There is an upward trend on the number of registered clinical trials (Figure 1).\n",
      "\n",
      "#10 sentence\n",
      "Cosine similarity:  0.10676250765557915\n",
      "PMC_ID:  nan\n",
      "gov), there are 125 clinical trials registered by February 18, 2020, focusing on the treatment of COVID-19.\n",
      "\n",
      "Query:  Efforts to determine adjunctive and supportive interventions that can improve the clinical outcomes of infected patients (e.g. steroids, high flow oxygen)\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vocabulary size:  521\n",
      "\n",
      "#1 sentence\n",
      "Cosine similarity:  0.1880222847727937\n",
      "PMC_ID:  nan\n",
      "Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.\n",
      "\n",
      "#2 sentence\n",
      "Cosine similarity:  0.18460622155568007\n",
      "PMC_ID:  PMC3016795\n",
      "Advanced age, high admission neutrophil count, and high initial lactate dehydrogenase level were independent correlates of an adverse clinical outcome.\n",
      "\n",
      "#3 sentence\n",
      "Cosine similarity:  0.16745303078738627\n",
      "PMC_ID:  PMC3016795\n",
      "The viral load could be a determinant of these prognostic association factors.\n",
      "\n",
      "#4 sentence\n",
      "Cosine similarity:  0.1548276968614941\n",
      "PMC_ID:  nan\n",
      "Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir.Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%).\n",
      "\n",
      "#5 sentence\n",
      "Cosine similarity:  0.1449047040648037\n",
      "PMC_ID:  PMC3016795\n",
      "Apparently, approximately one third responded to pulsed doses of steroids, while the other third depended on treatment with high amounts of oxygen.\n",
      "\n",
      "#6 sentence\n",
      "Cosine similarity:  0.1426599725017258\n",
      "PMC_ID:  nan\n",
      "Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI.\n",
      "\n",
      "#7 sentence\n",
      "Cosine similarity:  0.13583840843624473\n",
      "PMC_ID:  nan\n",
      "Evidence-based supportive care is the mainstay for management of severe respiratory viral infection.\n",
      "\n",
      "#8 sentence\n",
      "Cosine similarity:  0.1350767979079882\n",
      "PMC_ID:  PMC3016795\n",
      "Strong evidence to support early and routine use of ribavirin and steroid combination therapy in all SARS patients does not exist.\n",
      "\n",
      "#9 sentence\n",
      "Cosine similarity:  0.13458436652267336\n",
      "PMC_ID:  PMC3016795\n",
      "Advanced age, high neutrophil count on admission, and elevated initial lactate dehydrogenase level were independent correlates of an adverse clinical outcome.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "nDoc = 5\n",
    "nSent = 10\n",
    "dataPath = \"../../../Downloads/2020-03-13\"\n",
    "outputPath = \"../../../Downloads/2020-03-13/topSent.txt\" \n",
    "retrieveTopSent(queries, queryDocDist, dataPath, outputPath, nDoc, nSent)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Compared to the article retrieved based on abstracts, some of the sentences retrieved here are more specifically related to the query while others only contain part of the information, which may need complement from its context."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# III. Results summary for each task"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Below we provide a mixed short-cut of selected content from articles and sentences we retrieved for the queries of each task. We have been very cautious to not overextend any conclusions or observations reported in the original articles, and only add minimal modifications to make some sentences more readable. We also provide pmcid as the reference to the article that supports each statement wherever available. The summary was written based on the articles included in the dataset, which may no longer reflect the most up-to-date research progress in this active field."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 1: What is known about transmission, incubation, and environmental stability?\n",
    "Controversy remains about whether COVID-19 has infectivity during the incubation period. A case was reported that did not show infectivity during the incubation period. Another clustering outbreak case suggested asymptomatic patients may be the key point to control the epidemic. A shorter incubation period of SARS-CoV may associate with more severe disease (PMC_ID: PMC4889459). A longer incubation period of MERS-CoV may associate with a lower risk of death (PMC_ID: PMC4766874). Longer recovery delay of MERS-CoV was seen in patients of older age, ICU admission, and abnormal radiology findings (PMC_ID: PMC6086845). Before 2012, CoV infection was found not associated with hospitalization or with increased severity of illness for children hospitalized for acute respiratory illness and/or fever (PMC_ID: PMC3288315). COVID-19 are usually mild in children while prolonged virus shedding is observed in the respiratory tract and feces at the convalescent stage. Before COVID-19, CoV generally displayed in winter seasonality between December and April, except HCoV-229E (PMC_ID: PMC2916580). Viruses other than influenza may also be important contributors to hospitalization and mortality during the peak weeks of influenza seasons, especially for the elderly (PMC_ID: PMC4281811). The role of camels in the transmission of MERS-CoV has been confirmed (PMC_ID: PMC6518552, PMC_ID: PMC6518552). Hospital-associated transmission may have a larger role than direct contact with an infected camel in the spread of MERS-CoV (PMC_ID: PMC6518552). Studies have described the ability of CoVs to survive in different environmental conditions (e.g. temperature and humidity), on different supports found in hospital settings such as aluminum, sterile sponges or latex surgical gloves or in biological fluids (PMC_ID: PMC3509683). Nasal discharge showed a higher viral positivity than feces for bovine CoV, which seemed to be associated with positive detection in the plasma (PMC_ID: PMC6068295). In an evaluation of clinical specimens from SARS patients, 34 (52%) of 66 nasopharyngeal aspirate samples from 50 patients, 5 (5%) of 94 urine samples from 94 patients, and 36 (55%) of 65 fecal samples from 65 patients tested positive for SARS CoV nucleocapsid protein (PMC_ID: PMC446266). Pathogenic CoV-229E remained infectious in a human lung cell culture model following at least 5days of persistence on a range of common nonbiocidal surface materials, including polytetrafluoroethylene (Teflon; PTFE), polyvinyl chloride (PVC), ceramic tiles, glass, silicone rubber, and stainless steel (PMC_ID: PMC4659470). CoV-229E was rapidly inactivated on a range of copper alloys (within a few minutes for simulated fingertip contamination) and Cu/Zn brasses were very effective at lower copper concentration. Exposure to copper destroyed the viral genomes and irreversibly affected virus morphology, including disintegration of envelope and dispersal of surface spikes (PMC_ID: PMC4659470). Most viruses from the respiratory tract, including SARS, can persist on surfaces for a few days (PMC_ID: PMC1564025). The analysis of 22 studies reveals that human coronaviruses such as SARS-CoV, MERS-CoV or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 6271% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Alpacas may be suitable models for infection and shedding dynamics of MERS-CoV (PMC_ID: PMC4880109). Rhesus macaque and common marmoset have been established as animal models for MERS-CoV (PMC_ID: PMC4140844). A current limitation of animal models for CoV is that no animal model perfectly recapitulates the disease seen in humans (PMC_ID: PMC4811657). No evidence was found of changes in the evolutionary rate of MERS-CoV and no reason to suspect adaptive changes in viral proteins (PMC_ID: PMC4734539). Many, if not all, viruses, including CoV, suppress innate immune responses to gain a window of opportunity for efficient virus replication and setting-up of the infection (PMC_ID: PMC6959104). Potential targets have been identified for immune responses to COVID-19 and provide essential information for understanding human immune responses to this virus and evaluation of diagnostic and vaccine candidates. For SARS-CoV, the humoral immune response was enhanced most effectively through the use of inactivated virus with adjuvants, either MF59 or alum, and was associated with stimulation of the CD4 but not the CD8 response (PMC_ID: PMC1280202). MERS-CoV and SARS-CoV have evolved diverse strategies to evade and block host immune responses, facilitating infection and transmission (PMC_ID: PMC4821769).  Full precautions should be applied and carefully followed to prevent the transmission of MERS-CoV, especially among health care workers (PMC_ID: PMC6695009). For SARS-CoV, a study reported that there was no evidence of transmission of infection before symptom onset (PMC_ID: PMC2870589). The patients treated in the burn and wound care ward are susceptible to viral infection because of disease, age and other factors, so it is very important to manage the burn and wound care ward during the prevention and control of CoV epidemic. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. Contaminated surfaces may play a major role in transmission of SARS-CoV in the hospital and the community (PMC_ID: PMC3265313). The better stability of SARS-CoV at low temperature and low humidity environment may facilitate its transmission in community in subtropical area (such as Hong Kong) during the spring and in air-conditioned environments (PMC_ID: PMC3265313). In countries such as Singapore and Hong Kong where there is an intensive use of air-conditioning, transmission of SARS-CoV largely occurred in well-air-conditioned environments such as hospitals or hotels (PMC_ID: PMC3265313)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 2: What do we know about COVID-19 risk factors?\n",
    "Evidence of an impact of legislative bans on smoking prevalence and tobacco consumption is inconsistent, with some studies not detecting additional longterm change in existing trends in smoking prevalence or impact on respiratory and perinatal health outcomes (PMC_ID: PMC6486282). Coronavirus infection should be considered in differential diagnosis of respiratory tract illness in adults including those that require hospitalization, have a history of smoking and have pulmonary comorbidities (PMC_ID: PMC5631947). Pulmonary function testing procedures have been associated with an increasing risk of COVID-19 transmission among patients/subjects and medical staffs. It is strongly recommended to suspend the pulmonary function test for the confirmed or suspected cases of COVID-19 during the contagious stage, and to postpone the test for other patients if it is not imperative. H1N1 patients coinfected with rhinovirus had less severe disease while non-rhinovirus co-infections were associated with substantially higher severity without changes in influenza viral titer (PMC_ID: PMC3153592). There was a significant decrease in the duration of influenza A viral shedding in co-infections (of any respiratory viruses) compared to single infections (PMC_ID: PMC6625191). Respiratory viruses rarely reach their epidemic peak concurrently and there appears to be a negative association between infection with one respiratory virus and co-infection with another (PMC_ID: PMC6625191). Co-detections of specific clusters of viruses were observed in 9% of acute respiratory illness cases particularly in children, were less frequent in households without children, and were less symptomatic (e.g., lower fever) than single infections (PMC_ID: PMC4344779). Most frequently co-detected viruses were coronavirus, respiratory syncytial virus, and influenza A virus (PMC_ID: PMC4344779). Co-infection was less likely with increasing age, which may be a consequence of pre-existing immunity or decreased viral shedding with increasing age (PMC_ID: PMC6625191). Infection by rhinovirus may result in temporary immunity of the host to infection by other respiratory viruses due to the production of cytokines, thus resulting in a negative association between rhinovirus infection and co-infection with another virus (PMC_ID: PMC6625191). So far, no maternal deaths have been reported for women with COVID-19. There appears to be some risk of premature rupture of membranes, preterm delivery, fetal tachycardia and fetal distress when the infection occurs in the third trimester of pregnancy. There is no evidence suggesting transplacental transmission based on very limited data, as the analysis of amniotic fluid, cord blood, neonatal throat swab, and breast milk samples available from six of the nine patients were found to be negative for COVID-19. Whether virus shedding occurs vaginally is also not known. In general, the clinical characteristics of the pregnant women with COVID-19 pneumonia were similar to those of non-pregnant adult patients who developed COVID-19 pneumonia. Another study reported that the impact of COVID-19 infection on pregnant women appears to be less severe. Both SARS coronavirus and H7N9 viruses presented a global epidemic threat, but the social and economic impacts of H7N9 were not as serious as in the case of SARS because the response to H7N9 was more effective (PMC_ID: PMC6046118). A mathematical model for MERS-CoV transmission dynamics has been used to estimate the transmission rates in two periods due to the implementation of intensive interventions (PMC_ID: PMC4776270). The serial interval of COVID-19 is close to or shorter than its median incubation period. This suggests that a substantial proportion of secondary transmission may occur prior to illness onset. The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias. Among patients infected with a respiratory virus, risk of hospitalization was higher among underweight adult patients, and obese patients had a longer mean length of stay once hospitalized (PMC_ID: PMC6809817). Underweight children were not at increased risk of hospitalization (PMC_ID: PMC6809817). For MERS-CoV, increased age and underlying comorbidity were risk factors for both death and severe disease, while cases arising in Saudi Arabia were more likely to be severe (PMC_ID: PMC5023790). There is no significant association between alleles or genotypes of the MASP2 tagSNP and susceptibility to SARS-CoV in both Beijing and Guangzhou populations (PMC_ID: PMC2683852). MASP2 polymorphisms is not directly related to SARS-CoV susceptibility in northern and southern Chinese (PMC_ID: PMC2683852). Strong infection control and response measures were effective in controlling the outbreak of MERS-CoV in the Republic of Korea (PMC_ID: PMC4957609). Two of the most effective policy procedures to prevent infections of SARS-CoV would be to apply stringent precautionary measures and to impose quicker and more effective quarantine of the exposed populace (PMC_ID: PMC1732706)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 3: What do we know about virus genetics, origin, and evolution?\n",
    "A web-based tool (SummaryGenome Detective) was developed to allow tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. A web-based portal (WashU Virus Genome Browser) was developed for viewing virus genomic data, which is home to 16 complete 2019-nCoV genome sequences, together with hundreds of related viral sequences including SARS-CoV, MERS-CoV, and Ebola virus. Genetic and epidemiological evidence indicate camels serve as a reservoir for MERS virus (PMC_ID: PMC4720378). The emergence of MERS-CoV was believed to be of zoonotic origin from bats with dromedary camels as intermediate hosts. There is a likelihood of other domestic livestock serving as intermediate hosts for this virus (PMC_ID: PMC6473935). RNA-RNA recombination may play a significant role in natural evolution and neuropathogenesis of coronaviruses (PMC_ID: PMC253235). It is unclear whether higher virus load causally leads to severe outcomes of MERS-CoV (PMC_ID: PMC4622256). Wildlife trade can facilitate zoonotic disease transmission and represents a threat to human health and economies in Asia, highlighted by the 2003 SARS coronavirus outbreak, where a Chinese wildlife market facilitated pathogen transmission (PMC_ID: PMC4805265). Highly pathogenic viruses elicit expression of many of the same key genes as lower pathogenic viruses but to a higher degree. This increased degree of expression may result in the uncontrolled co-localization of inflammatory cell types and lead to irreversible host damage (PMC_ID: PMC3297540). In addition to SARS, the highly pathogenic avian influenza virus (AIV), H5N1, and the lower pathogenicity H9N2 AIV have expanded their host ranges to infect human beings and other mammalian species as well as birds (PMC_ID: PMC2865088). Viruses that originate in bats may be the most notorious emerging zoonoses that spill over from wildlife into domestic animals and humans (PMC_ID: PMC4262174). Transmission of viruses from bats to humans requires a hierarchy of enabling conditions that connect the distribution of reservoir hosts, viral infection within these hosts, and exposure and susceptibility of recipient hosts (PMC_ID: PMC4262174). The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV (PMC_ID: PMC5287300). Demographic factors, such as race, smoking status, and socioeconomic status, may confer an increased risk of susceptibility to viruses including CoV (PMC_ID: PMC2593164)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 4: What do we know about vaccines and therapeutics?\n",
    "Drugs developed for HIV and Ebola are being tested for treating COVID-19. In the epidemic of COVID-19, front-line medical staff in emergency traumatic orthopedics is faced with great challenges in the process of diagnosing and treating patients. Lung computed tomography images are being used for supporting the diagnosis of COVID-19. It is considered particularly important for medical institutions of all levels to maintain safe and effective routine services while doing well in COVID-19 prevention. Viral protease inhibitors are remarkably effective at blocking the replication of viruses such as human immunodeficiency virus and hepatitis C virus, but they inevitably lead to the selection of inhibitor-resistant mutants, which may contribute to ongoing disease (PMC_ID: PMC4178758). To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China for COVID-19. From the Chinese Clinical Trial Registry (http://www.chictr.org.cn) and U.S. National Library of Medicine Clinical Trial Registry (https://clinicaltrials. gov), there are 125 clinical trials registered by February 18, 2020, focusing on the treatment of COVID-19. There is an upward trend on the number of registered clinical trials. Among the 125 clinical trials on treatment, 33.3% used anti-viral agents, 14.7% anti-inflammation or immunomodulators, 33.3% herbs or traditional Chinese medicine (TCM), 9.3% cell-based therapy, 2.3% antioxidation and 7.0% other approaches. Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARS-CoV. The nucleocapsid (N) protein of COVID-19 has nearly 90% amino acid sequence identity with SARS-CoV. The N protein antibodies of SARS-CoV may cross react with COVID-19 but may not provide cross-immunity. Antibody-dependent enhancement (ADE) of viral entry has been a major concern for epidemiology, vaccine development, and antibody-based drug therapy. The discrepancy between the severity of cases observed in the Hubei province of China and those occurring elsewhere in the world may due to the antibody dependent enhancement (ADE) of SARS-CoV-2 due to prior exposure to other coronaviruses. Antibody-dependent enhancement (ADE), a phenomenon in which viral replication is increased rather than decreased by immune sera, has been observed in vitro for a large number of viruses of public health importance, including flaviviruses, coronaviruses, and retroviruses (PMC_ID: PMC1257724). Vaccination is a major strategy for containing resurgence of SARS in humans, and a number of vaccine candidates have been tested in experimental animal models (PMC_ID: PMC3187504). In general, the potential vaccine candidates for MERS-CoV can be classified into six types: viral vector-based vaccine, DNA vaccine, subunit vaccine, nanoparticle-based vaccine, inactivated-whole virus vaccine and live-attenuated vaccine (PMC_ID: PMC6688523). Animal models are utilized to gain insight into the pathogenesis of disease with the overall goal of identifying potential targets for intervention and evaluating specific therapeutics and vaccines (PMC_ID: PMC3644300). MERS-CoV has been used to screen FDA-approved drugs identify potential therapeutic options for treatment of MERS-CoV infections and provide a basis for potential therapeutic options for COVID-19. COVID-19 imaging characteristic mainly has subpleural, centrilobular and diffused distribution. N protein can be used as an early diagnostic maker for SARS (PMC_ID: PMC3329003). Several types of vaccines have been developed for SARS-CoV including inactivated viruses, subunit vaccines, virus-like particles (VLPs), DNA vaccines, heterologous expression systems, and vaccines derived from SARS-CoV genome by reverse genetics (PMC_ID: PMC2633062). Transgenic mouse model has been developed for MERS-CoV (PMC_ID: PMC4403411). The standard small animals, mice, hamsters, and ferrets, all lack the functional MERS-CoV receptor and are not susceptible to infection (PMC_ID: PMC4403411). Camel vaccination for MERS-CoV may be a novel approach to preventing the human infection (PMC_ID: PMC4969153). For SARS-CoV, evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease (PMC_ID: PMC3335060). The majority of MERS vaccines under development are based on MERS-CoV S protein, including full-length S, S1, and receptor-binding domain (RBD). (PMC_ID: PMC6355461)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 5: What has been published about medical care?\n",
    "While ensuring the completion of treatment work of COVID-19, Beijing You'an Hospital manage to leverage nursing human resources in a scientific, standardized and maximized efficiency manner, to ensure the quality of nursing, and the physical and mental health of nursing staff. The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges such as the new coronavirus COVID-19. Ninety-seven percent (181/186) of the MERS-CoV cases in Korea had exposure to the health care facilities (PMC_ID: PMC4630490). Three outbreaks of HCoV-OC43 in Melbourne establish this virus as a cause of morbidity in aged-care facilities and add to increasing evidence of the significance of coronavirus infections (PMC_ID: PMC2870246). All healthcare facilities should establish and implement infection prevention and control measure as well as triage policies and procedures for early detection and isolation of suspected MERS-CoV cases (PMC_ID: PMC4630490). In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses. In hospitals there is above average risk for exposure to infectious diseases (PMC_ID: PMC4405869). The following baseline factors were independently associated with worse survival of SARS-CoV: older age (6180 years), presence of an active comorbid condition and higher initial viral load of SARS coronavirus (PMC_ID: PMC527336). For MERS-CoV, hospital mortality was 25%; septic shock/organ failure at admittance was a significant predictor of mortality ()."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 6: What do we know about non-pharmaceutical interventions?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 7: Sample task with sample submission"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 8: What do we know about diagnostics and surveillance?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 9: What has been published about ethical and social science considerations?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Task 10: What has been published about information sharing and inter-sectoral collaboration?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
